學術研究成果/Publication
|
基本資料/Profiles
|
姓名/Name: |
徐偉成
|
性別/Gender: |
男
|
英文姓名/ English Name: |
Woei-Cheang Shyu
|
英文縮寫/ Abbreviation: |
|
任職單位/ Affiliation: |
1.醫學院生物醫學研究所(教授) / Graduate Institute of Biomedical Sciences (Professor) 2.中國附醫神經部神經免疫暨基因疾病科(榮譽副院長) / Neuroimmune and Neurogenetic Disorders (Honorary Vice Superintendent)
|
Email: |
shyu9423@gmail.com
|
研究專長/Fields of Specialty
|
1﹒ |
臨床神經學
|
2﹒ |
神經免疫學
|
3﹒ |
基礎神經科學
|
4﹒ |
細胞及分子生物學
|
|
期刊論文/Journal Paper (作者群,論文題目,期刊名稱,出版年月,卷號(期別):頁次起迄)
|
SCI論文 |
林育楷(Yu-Kai Lin)、蕭連城(Lien-Cheng Hsiao)、吳美瑤(Mei-Yao Wu)、(Yun-Fang Chen)、林晏年(Yen-Nien Lin)、張家銘(Chia-Ming Chang)、鍾偉信(CHUNG WEI-HSIN)、陳科維(Ke-Wei Chen)、盧炯睿(Chiung-Ray Lu)、(Wei-Yu Chen)、徐偉成(Woei-Cheang Shyu)、張詩聖(Shih-Sheng Chang)、李安生(An-Sheng Lee)*、(Chu-Huang Chen)、鄭隆賓(Long-Bin Jeng)*、張坤正(Kuan-Cheng Chang)*,PD-L1 and AKT Overexpressing Adipose-Derived Mesenchymal Stem Cells Enhance Myocardial Protection by Upregulating CD25+ T Cells in Acute Myocardial Infarction Rat Model,INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES,2023 Dec,():
|
SCI論文 |
林瑄翎(LIN SYUAN-LING)、李瑋(Wei Lee)、劉詩平(Shih-Ping Liu)、張怡雯(CHANG YI-WEN)*、鄭隆賓(Long-Bin Jeng)*、徐偉成(Woei-Cheang Shyu)*,Novel Programmed Death Ligand 1‑AKT‑engineered Mesenchymal Stem Cells Promote Neuroplasticity to Target Stroke Therapy,MOLECULAR NEUROBIOLOGY,2023 Nov,s12035(023):3779-3796
|
SCI論文 |
王啟鴻(Wang, Chie-Hong)、(Yi-Fang Huang)、徐偉成(Woei-Cheang Shyu)*、鄭隆賓(Long-Bin Jeng)*、劉詩平(Shih-Ping Liu)*,Cbx7 promotes the generation of induced pluripotent stem cells,Regenerative Therapy,2023 Sep,():
|
SCI論文 |
傅如輝(Ru-Huei Fu)*、洪宣羽(Syuan-Yu Hung)、(Chia-Wen Tsai)、劉詩平(Shih-Ping Liu)、邱紹智(Shao-Chih Chiu)、吳孟蓁(Wu, Meng-Zhen)、徐偉成(Woei-Cheang Shyu)、(Shinn-Zong Lin),Interaction of a Novel Alternatively Spliced Variant of HSD11B1L with Parkin Enhances the Carcinogenesis Potential of Glioblastoma: Peiminine Interferes with This Interaction,Cells,2023 Mar,12(6):894
|
SCI論文 |
賴彥合(LAI YEN-HO)、(Chia-Yu Su)、(Hung-Wei Cheng)、(Chao-Yi Chu)、鄭隆賓(Long-Bin Jeng)、江智聖(CHIANG, CHIH-SHENG)*、徐偉成(Woei-Cheang Shyu)*、陳三元*,Stem cell–nanomedicine system as a theranostic bio-gadolinium agent for targeted neutron capture cancer therapy,Nature Communications,2023 Jan,14(1):285
|
SCI論文 |
傅如輝(Ru-Huei Fu)*、蔡佳文(Chia-Wen Tsai)、邱紹智(Shao-Chih Chiu)、劉詩平(Shih-Ping Liu)、蔣郁亭(Chiang, Yu-Ting)、(Yun-Hua Kuo)、徐偉成(Woei-Cheang Shyu)、(Shinn-Zong Lin),C9-ALS-Associated Proline-Arginine Dipeptide Repeat Protein Induces Activation of NLRP3 Inflammasome of HMC3 Microglia Cells by Binding of Complement Component 1 Q Subcomponent-Binding Protein (C1QBP), and Syringin Prevents This Effect,Cells,2022 Oct,11(19):3128
|
SCI論文 |
林瑄翎(LIN SYUAN-LING)、林智暘(Chih-Yang Lin)、李瑋(Wei Lee)、鄧喬方(Chiao-Fang Teng)、徐偉成(Woei-Cheang Shyu)*、鄭隆賓(Long-Bin Jeng)*,Mini Review: Molecular Interpretation of the IGF/IGF-1R Axis in Cancer Treatment and Stem Cells-Based Therapy in Regenerative Medicine,INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES,2022 Oct,23(19):11781-11795
|
SCI論文 |
傅如輝(Ru-Huei Fu)*、蔡佳文(Chia-Wen Tsai)、劉詩平(Shih-Ping Liu)、邱紹智(Shao-Chih Chiu)、陳妍涓(Yen-Chuan Chen)、蔣郁亭(Chiang, Yu-Ting)、(Yun-Hua Kuo)、徐偉成(Woei-Cheang Shyu)、(Shinn-Zong Lin),Neuroprotective Capability of Narcissoside in 6-OHDA-Exposed Parkinson’s Disease Models through Enhancing the MiR200a/Nrf-2/GSH Axis and Mediating MAPK/Akt Associated Signaling Pathway,Antioxidants,2022 Oct,11():2089
|
SCI論文 |
陳智皓(CHEN CHIH-HAO)、張坤正(Kuan-Cheng Chang)*、林晏年(Yen-Nien Lin)、何茂旺(Mao-Wang Ho)、鄭孟瑜(Meng-Yu Cheng)、施文心(HSIH WEN HSIN)、周家卉(Chia-Hui Chou)、林伯昌(Po-Chang Lin)、齊治宇(Chih-Yu Chi)、盧敏吉(Min-Chi Lu)、田霓(Ni Tien)、吳美瑤(Mei-Yao Wu)、張詩聖(Shih-Sheng Chang)、徐武輝(Wu-Huei Hsu)、徐偉成(Woei-Cheang Shyu)*、周德陽(Der-Yang Cho)、鄭隆賓(Long-Bin Jeng)*,Mesenchymal Stem Cell Therapy on Top of Triple Therapy with Remdesivir, Dexamethasone, and Tocilizumab Improves PaO2/FiO2 in Severe COVID-19 Pneumonia,Frontiers in Medicine,2022 Sep,():
|
SCI論文 |
(Yun-Hua Kuo)、洪慧珊(Huey-Shan Hung)、蔡佳文(Chia-Wen Tsai)、邱紹智(Shao-Chih Chiu)、劉詩平(Shih-Ping Liu)、蔣郁亭(Chiang, Yu-Ting)、徐偉成(Woei-Cheang Shyu)、(Shinn-Zong Lin)、傅如輝(Ru-Huei Fu)*,A Novel Splice Variant of BCAS1 Inhibits β-Arrestin 2 to Promote the Proliferation and Migration of Glioblastoma Cells, and This Effect was Blocked by Maackiain,Cancers,2022 Aug,14(16):3890
|
SCI論文 |
蕭連城(Lien-Cheng Hsiao)、林晏年(Yen-Nien Lin)、徐偉成(Woei-Cheang Shyu)、何銘(Ming- Ho)、盧炯睿(Chiung-Ray Lu)、張詩聖(Shih-Sheng Chang)、王宇澄(Yu-Chen Wang)、陳建佑(Jan-Yow Chen)、呂尚謁(Shang-yeh Lu)、吳美瑤(Mei-Yao Wu)、李庚原(Keng-Yuan Li)、林育楷(Yu-Kai Lin)、(Wen-Yih I. Tseng)、(Mao-Yuan Su)、(Chin-Ting Hsu)、(Cheng-Kang Tsai)、(Lu-Ting Chiu)、(Chien-Lin Chen)、林橙莉(Cheng-Li Lin)、胡凱傑、周德陽(Der-Yang Cho)、蔡長海(Chang-Hai Tsai)、張坤正(Kuan-Cheng Chang)*、鄭隆賓(Long-Bin Jeng)*,First-in-Human Pilot Trial of Combined Intracoronary and Intravenous Mesenchymal Stem Cell Therapy in Acute Myocardial Infarction,Frontiers in Cardiovascular Medicine,2022 Jul,():
|
SCI論文 |
(Jong-Ho Cha)、(Li-Chuan Chan)、(Ying-Nai Wang)、(Yu-Yi Chu)、王啟鴻(Wang, Chie-Hong)、(Heng-Huan Lee)、(Weiya Xia)、徐偉成(Woei-Cheang Shyu)、劉詩平(Shih-Ping Liu)、(Jun Yao)、(Chiung-Wen Chang)、(Fan-Ru Cheng)、(Jielin Liu)、(Seung-Oe Lim)、(Jennifer L. Hsu)、楊文豪(Yang,Wen-Hao)、(Gabriel N. Hortobagyi)、(Chunru Lin)、(Liuqing Yang)、(Dihua Yu)、鄭隆賓(Long-Bin Jeng)*、洪明奇(Mien-Chie Hung)*,Ephrin receptor A10 monoclonal antibodies and the derived chimeric antigen receptor T cells exert an antitumor response in mouse models of triple-negative breast cancer,JOURNAL OF BIOLOGICAL CHEMISTRY,2022 Apr,298(4):101817-101832
|
SCI論文 |
(Hung-Wei Cheng)、江智聖(CHIANG CHIH-SHENG)、(Hsin-Yao Ho)、(Syun-Hong Chou)、(Yen-Ho Lai)、徐偉成(Woei-Cheang Shyu)*、(San-Yuan Chen),Dextran-modified Quercetin-Cu(II)/Hyaluronic Acid Nanomedicine with Natural Poly(ADP-Ribose) Polymerase Inhibitor and Dual Targeting for Programmed Synthetic Lethal Therapy in Triple-negative Breast Cancer,JOURNAL OF CONTROLLED RELEASE,2021 Dec,2(329):136-147
|
SCI論文 |
江智聖(CHIANG, CHIH-SHENG)*、黃柏傑(HUANG BO-JIE)、陳睿妤(CHEN JUI-YU)、錢韋薇(CHIENG WEE-WEI)、(Seh Hing Lim)、李瑋、徐偉成(Woei-Cheang Shyu)*、鄭隆賓(Long-Bin Jeng)*,Fucoidan-Based Nanoparticles with Inherently Therapeutic Efficacy for Cancer Treatment,Pharmaceutics,2021 Nov,13(12):1986
|
SCI論文 |
徐佑靈(Hsu, Yu-Ling)、洪慧珊(Huei-Shan Hung)、蔡佳文(Chia-Wen Tsai)、劉詩平(Shih-Ping Liu)、蔣郁亭(Chiang, Yu-Ting)、(Yun-Hua Kuo)、徐偉成(Woei-Cheang Shyu)、(Shinn-Zong Lin)、傅如輝(Ru-Huei Fu)*,Peiminine Reduces ARTS-Mediated Degradation of XIAP by Modulating the PINK1/Parkin Pathway to Ameliorate 6-Hydroxydopamine Toxicity and α-Synuclein Accumulation in Parkinson Disease Models in Vivo and in Vitro,INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES,2021 Oct,22(19):10240
|
SCI論文 |
鄧喬方(Chiao-Fang Teng)*、王庭(Ting Wang)、施富瀛(SHIH FU-YING)、徐偉成(Woei-Cheang Shyu)*、鄭隆賓(Long-Bin Jeng)*,Therapeutic Efficacy of Dendritic Cell Vaccine Combined with Programmed Death 1 Inhibitor for Hepatocellular Carcinoma,JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY,2021 Jul,36(7):1988-1996
|
SCI論文 |
鄧喬方(Chiao-Fang Teng)*、李采娟(Tsai-Chung Li)、王庭(Ting Wang)、廖大慶(Liao Da Ching)、文翊軒(Yi-Hsuan Wen)、吳慈華(Tzu-Hua Wu)、王約翰(John Wang)、吳漢傑(Han-Chieh Wu)、徐偉成(Woei-Cheang Shyu)、蘇益仁(Ih-Jen Su)、鄭隆賓(Long-Bin Jeng)*,Increased Infiltration of Regulatory T Cells in Hepatocellular Carcinoma of Patients with Hepatitis B Virus Pre-S2 Mutant,Scientific Reports,2021 Jan,11(1):1136
|
SCI論文 |
鄧喬方(Chiao-Fang Teng)*、李采娟(Tsai-Chung Li)、王庭(Ting Wang)、吳慈華(Tzu-Hua Wu)、王約翰(John Wang)、吳漢傑(Han-Chieh Wu)、徐偉成(Woei-Cheang Shyu)、蘇益仁(Ih-Jen Su)、鄭隆賓(Long-Bin Jeng)*,Increased Expression of Programmed Death Ligand 1 in Hepatocellular Carcinoma of Patients with Hepatitis B Virus Pre-S2 Mutant,Journal of Hepatocellular Carcinoma,2020 Dec,7():385-401
|
SCI論文 |
鄧喬方(Chiao-Fang Teng)*、李采娟(Tsai-Chung Li)、黃熙淵(Hsi-Yuan Huang)、詹雯玲(Wen-Ling Chan)、吳漢傑(Han-Chieh Wu)、徐偉成(Woei-Cheang Shyu)、蘇益仁(Ih-Jen Su)*、鄭隆賓(Long-Bin Jeng)*,Hepatitis B virus pre-S2 deletion (nucleotide 1 to 54) in plasma predicts recurrence of hepatocellular carcinoma after curative surgical resection,PLoS One,2020 Nov,15(11):e0242748
|
SCI論文 |
江智聖(CHIANG CHIH-SHENG)、高譽哲(Yu-Che Kao)、(Thomas J. Webster)、徐偉成(Woei-Cheang Shyu)、鄭宏偉(Hung-Wei Cheng)、劉澤英(Tse-Ying Liu)、陳三元(San-Yuan Chen)*,Circulating Tumour Cells-Targeting Au-Nanocages-Mediated Bimodal Phototherapeutic Properties Enriched by Magnetic Nanocore,Journal of Materials Chemistry B,2020 Jul,8(0):5460-5471
|
SCI論文 |
鄧喬方(Chiao-Fang Teng)*、李采娟(Tsai-Chung Li)、黃熙淵(Hsi-Yuan Huang)、林佳慧(Jia-Hui Lin)、陳雯淑(Wen-Shu Chen)、徐偉成(Woei-Cheang Shyu)、吳漢傑(Han-Chieh Wu)、彭成元(Cheng-Yuan Peng)、蘇益仁(Ih-Jen Su)*、鄭隆賓(Long-Bin Jeng)*,Next-Generation Sequencing-Based Quantitative Detection of Hepatitis B Virus Pre-S Mutants in Plasma Predicts Hepatocellular Carcinoma Recurrence,Viruses-Basel,2020 Jul,12(8):796
|
SCI論文 |
邱曉郁(Hsiao-Yu Chiu)、李旭東(Hsu-Tung Lee)、李國雄(Kuo-Hsiung Lee)、趙昱(Yu Zhao)、許重義(Chung Y. Hsu)、徐偉成(Woei-Cheang Shyu)*,Mechanisms of ischaemic neural progenitor proliferation: a regulatory role of the HIF-1α-CBX7 pathway,NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY,2020 Jun,46(4):391-405
|
SCI論文 |
鄧喬方(Chiao-Fang Teng)*、王庭(WANG TING)、吳慈華(Tzu-Hua Wu)、林佳慧(Jia-Hui Lin)、施富瀛(SHIH FU-YING)、徐偉成(Woei-Cheang Shyu)*、鄭隆賓(Long-Bin Jeng)*,Combination Therapy with Dendritic Cell Vaccine and Programmed Death Ligand 1 Immune Checkpoint Inhibitor for Hepatocellular Carcinoma in An Orthotopic Mouse Model,Therapeutic Advances in Medical Oncology,2020 Jun,12():1758835920
|
SCI論文 |
鄧喬方(Chiao-Fang Teng)*、蔡弘文(Hung-Wen Tsai)、李采娟(Tsai-Chung Li)、王庭(Ting Wang)、王約翰(John Wang)、徐偉成(Woei-Cheang Shyu)、吳漢傑(Han-Chieh Wu)、蘇益仁(Ih-Jen Su)*、鄭隆賓(Long-Bin Jeng)*,Detection of Hepatitis B Virus Pre-S Mutants in Plasma by A Next-Generation Sequencing-Based Platform Determines Their Patterns in Liver Tissues,PLoS One,2020 Jun,15(6):e0234773
|
SCI論文 |
(Rong-Tzong Tsai)、蔡佳文、劉詩平(Shih-Ping Liu)、高佳昕(Kao, Chia-Hsin)、(Yun-Hua Kuo)、趙蓓敏(Pei-Min Chao)、洪慧珊(Huei-Shan Hung)、徐偉成(Woei-Cheang Shyu)、(Shinn-Zong Lin)、傅如輝(Ru-Huei Fu)*,Maackiain Ameliorates 6-Hydroxydopamine and SNCA Pathologies by Modulating the PINK1/Parkin Pathway in Models of Parkinson’s Disease in Caenorhabditis elegans and the SH-SY5Y Cell Line,INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES,2020 Jun,21(12):E4455
|
SCI論文 |
魏嵩泰(Sung-Tai Wei)、黃彥智(Yen-Chih Huang)、(Mei-Ling Hsieh)、(Yu-Jung Lin)、徐偉成(Woei-Cheang Shyu)、陳惠珍、謝佳宏(Chia-Hung Hsieh)*,Atypical chemokine receptor ACKR3/CXCR7 controls postnatal vasculogenesis and arterial specification by mesenchymal stem cells via Notch signaling,Cell Death & Disease,2020 May,11(5):307
|
SCI論文 |
林懿苑(Yi-Yuan Lin)、(Yi Hong)、(Ming-Cheng Zhou)、(Hai-Liang Huang)、徐偉成(Woei-Cheang Shyu)、陳卓昇(Jwo-Sheng Chen)、丁化(Hua Ting)、鄭宇容(Cheng, Yu-Jung)、楊艾倫(Ai-Lun Yang)*、李信達(Shin-Da Lee)*,Exercise Training Attenuates Cardiac Inflammation and Fibrosis in Hypertensive Ovariectomized Rats,JOURNAL OF APPLIED PHYSIOLOGY,2020 Apr,128(4):1033-1043
|
SCI論文 |
王啟鴻、(Cheng-Hsuan Chang)、林宗立(Tsung-Li Lin)、傅如輝(Ru-Huei Fu)、黃毓銓(Yu-Chuen Huang)、陳世殷(Shih-Yin Chen)、徐偉成(Woei-Cheang Shyu)、劉詩平(Shih-Ping Liu)*,The novel application of cordycepin in maintaining stem cell pluripotency and increasing iPS cell generation efficiency,Scientific Reports,2020 Feb,10():2187
|
SCI論文 |
李怡慧(Li, Yi-Hui)、李旭東(Hsu-Tung Lee)、陳建霖(Chien-Lin Chen)、張其皓(Chi-Hao Chang)、許重義(Chung Y. Hsu)、徐偉成(Woei-Cheang Shyu)*,Role of FOXC1 in regulating APSCs self-renewal via STI-1/PrPC signaling,Theranostics,2019 Jul,9(22):6443-6465
|
SCI論文 |
林懿苑(Lin, Yi-Yuan)、洪怡(Yi Hong)、(Shao-Hong Yu)、吳緒波(Xu-Bo Wu)、徐偉成(Woei-Cheang Shyu)、陳卓昇(Jwo-Sheng Chen)、丁化(Hua Ting)、楊艾倫(Ai-Lun Yang)*、李信達(Shin-Da Lee)*,Antiapoptotic and mitochondrial biogenetic effects of exercise training onovariectomized hypertensive rat hearts,JOURNAL OF APPLIED PHYSIOLOGY,2019 Jun,126(6):1661-1672
|
SCI論文 |
林懿苑(Lin, Yi-Yuan)、陳卓昇(Jwo-Sheng Chen)、吳緒波(Xu-Bo Wu)、徐偉成(Woei-Cheang Shyu)、(Rungchai Chaunchaiyakul)、任曉莉(Xian-Li Zhao)、郭家驊(Chia-Hua Kuo)、鄭宇容、楊艾倫(Ai-Lun Yang)*、李信達(Shin-Da Lee)*,Combined effects of 17β-estradiol and exercise training on cardiac apoptosis in ovariectomized rats,PLoS One,2018 Dec,13(12):
|
SCI論文 |
鄧喬方(Chiao-Fang Teng)*、黃熙淵(Hsi-Yuan Huang)、李采娟(Tsai-Chung Li)、徐偉成(Woei-Cheang Shyu)、吳漢傑(Han-Chieh Wu)、林建佑(Chien-Yu Lin)、蘇益仁(Ih-Jen Su)*、鄭隆賓(Long-Bin Jeng)*,A Next-Generation Sequencing-Based Platform for Quantitative Detection of Hepatitis B Virus Pre-S Mutants in Plasma of Hepatocellular Carcinoma Patients,Scientific Reports,2018 Oct,8(1):14816
|
SCI論文 |
鄧喬方(Teng, Chiao-Fang)、鄭隆賓(Jeng, Long-Bin)*、徐偉成(Shyu, Woei-Cherng)*,Role of Insulin-like Growth Factor 1 Receptor Signaling in Stem Cell Stemness and Therapeutic Efficacy,CELL TRANSPLANTATION,2018 Sep,27(9):1313-1319
|
SCI論文 |
黃敏偉、(Yu-Jung Lin)、(Chi-Wei Chang)、(Fu-Ju Lei)、(En-Peng Ho)、(Ren-Shyan Liu)、徐偉成(Shyu, Woei-Cherng)、謝佳宏(Hsieh, Chia-Hung)*,RGS4 Deficit in Prefrontal Cortex Contributes to the Behaviors related to Schizophrenia via System xc–-mediated Glutamatergic Dysfunction in Mice,Theranostics,2018 Sep,8(17):4781-4794
|
SCI論文 |
江智聖(CHIANG CHIH-SHENG)、林佑融(Yu-Jung Lin)、李欣餘(Rachel Lee)、賴彥合(Yen-Ho-Lai)、鄭宏偉(Hung-Wei Cheng)、謝佳宏(Hsieh, Chia-Hung)*、徐偉成(Shyu, Woei-Cherng)*、陳三元(San-Yuan Chen)*,Combination of fucoidan-based magnetic nanoparticles and immunomodulators enhances tumour-localized immunotherapy,Nature Nanotechnology,2018 Aug,13():746-754
|
SCI論文 |
詹佳穎(Jan, Chia-Ing)、蔡宛臻、韓鴻志(Horng-Jyh Harn)、徐偉成(Shyu, Woei-Cherng)、劉銘超(Liu, Ming-Chao)、呂欣蔓(Lu, Hsin Man)、邱紹智(Chiu, Shao-Chih)*、周德陽(Cho, Der-Yang)*,Predictors of Response to Autologous Dendritic Cell Therapy in Glioblastoma Multiforme,Frontiers in Immunology,2018 May,9(727):
|
SCI論文 |
(Jia-Rong Fan)、(Hsu-Tung Lee)、(Wei Lee)、(Chen-Huan Lin)、謝佳宏(Chia-Hung Hsieh)*、徐偉成(Woei-Cheang Shyu)*,Potential role of CBX7 in regulating pluripotency of adult human pluripotent-like olfactory stem cells in stroke model,Cell Death & Disease,2018 May,9(5):1-19
|
SCI論文 |
王啟鴻、林宗立(Tsung-Li Lin)、(Chih-Hsin Muo)、(Chen-Huan Lin)、黃毓銓(Huang, Yu-Chuen)、傅如輝(Fu, Ru-Huei)、徐偉成(Shyu, Woei-Cherng)、劉詩平(Liu, Shih-Ping)*,Increase of Meningitis Risk in Stroke Patients in Taiwan,Frontiers in Neurology,2018 Mar,9():
|
SCI論文 |
劉詩平(Liu, Shih-Ping)、(Yu-Hung Hsu)、(Ching-Ying Huang)、(Ming-Ching Ho)、(Yu-Che Cheng)、(Cheng-Hao Wen)、(Huai-En Lu)、(Chon-Haw Tsai)、徐偉成(Shyu, Woei-Cherng)*、(Patrick C.H. Hsieh)*,Generation of novel induced pluripotent stem cell (iPSC) line from a 16-year-old Sialidosis patient with NEU-1 gene mutation,Stem Cell Research,2018 Jan,28():
|
SCI論文 |
邱曉郁(Hsiao-Yu Chiu)、林振寰(Chen-Huan Lin)、許重義(Chung Y. Hsu)、游正博(John Yu)*、謝佳宏(Chia-Hung Hsieh)*、徐偉成(Woei-Cherng Shyu)*,IGF1R(+) Dental Pulp Stem Cells Enhanced Neuroplasticity in Hypoxia-Ischemia Model,MOLECULAR NEUROBIOLOGY,2017 Dec,10(54):8225-8241
|
SCI論文 |
蔡佳文(Chia-Wen Tsai)、(Rong-Tzong Tsai)、劉詩平(Shih-Ping Liu)、(Chang-Shi Chen)、(Min-Chen Tsai)、簡韶萱、洪慧珊(Huey-Shan Hung)、(Shinn-Zong Lin)、徐偉成(Woei-Cherng Shyu)、傅如輝(Ru-Huei Fu)*,Neuroprotective Effects of Betulin in Pharmacological and Transgenic C. elegans Models of Parkinson’s Disease,CELL TRANSPLANTATION,2017 Dec,26(12):1903-1918
|
SCI論文 |
林懿苑(Yi-Yuan Lin)、謝博軒(Po-Shiuan Hsieh)、鄭宇容(Cheng, Yu-Jung)、鄭秀敏(Shiu-Min Cheng)、陳喬男(Chiao-nan (Joyce) Chen)、黃志揚(Chih-Yang Huang)、郭家驊(Chia-Hua Kuo)、高崇蘭(Chung-Lan Kao)、徐偉成(Woei-Cherng Shyu)、李信達(Shin-Da Lee)*,Anti-apoptotic and Pro-survival Effects of Food Restriction on High-Fat Diet-Induced Obese Hearts,Cardiovascular Toxicology,2017 Apr,17(2):163-174
|
SCI論文 |
(Yu-Jung Lin)、徐偉成(Woei-Cherng Shyu)、(Chi-Wei Chang)、(Chi-Chung Wang)、(Chung-Pu Wu)、(Hsu-Tung Lee)、(Liang-Jwu Chen)*、謝佳宏(Chia-Hung Hsieh)*,Tumor Hypoxia Regulates Forkhead Box C1 to Promote Lung Cancer Progression,Theranostics,2017 Apr,7(5):1177-1191
|
SCI論文 |
鄧喬方(Chiao-Fang Teng)、吳漢傑(Han-Chieh Wu)、徐偉成(Woei-Cherng Shyu)、鄭隆賓(Long-Bin Jeng)*、蘇益仁(Ih-Jen Su)*,Pre-S2 Mutant-Induced Mammalian Target of Rapamycin Signal Pathways as Potential Therapeutic Targets for Hepatitis B Virus-Associated Hepatocellular Carcinoma,CELL TRANSPLANTATION,2017 Mar,26(3):429-438
|
SCI論文 |
謝佳宏(Chia-Hung Hsieh)*、Yu-Jung Lin、(Wei-Ling Chen)、(Yen-Chih Huang)、(Chi-Wei Chang)、(Fu-Chou Cheng)、(Ren-Shyan Liu)、徐偉成(Woei-Cherng Shyu)*,HIF-1α triggers long-lasting glutamate excitotoxicity via system xc- in cerebral ischaemia-reperfusion,JOURNAL OF PATHOLOGY,2017 Feb,241(3):337-349-2016Online
|
SCI論文 |
李旭東(Hsu-Tung Lee)、劉詩平(Shih-Ping Liu)、林振寰(Chen-Huan Lin)、李瑋(Sophie Wei Lee)、許重義(Chung Y. Hsu)、司徒惠康(Huey-Kang Sytwu)、謝佳宏(Chia-Hung Hsieh)*、徐偉成(Woei-Cherng Shyu)*,A Crucial Role of CXCL14 for Promoting Regulatory T Cells Activation in Stroke,Theranostics,2017 Feb,7():
|
SCI論文 |
林懿苑(Lin, Yi-Yuan)、鄭宇容(Cheng, Yu-Jung)、胡軍(Jun Hu)、禇立希(Li-Xi Chu)、徐偉成(Woei-Cherng Shyu)、高崇蘭(Chung-Lan Kao)、林則彬(Tzer-Bin Lin)、郭家驊(Chia-Hua Kuo)、楊艾倫(Ai-Lun Yang)*、李信達(Shin-Da Lee)*,The Coexistence of Hypertension and Ovariectomy Additively Increases Cardiac Apoptosis,INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES,2016 Dec,17(12):E2036
|
SCI論文 |
李旭東(Hsu-Tung Lee)、張顥騰(Hao-Teng Chang)、李瑋(Sophie Lee)、林振寰、范嘉榕(Jia-Rong Fan)、林欣榮(Shinn-Zong Lin)、許重義(Chung Y. Hsu)、謝佳宏(Chia-Hung Hsieh)*、徐偉成(Woei-Cherng Shyu)*,Role of IGF1R+ MSCs in modulating neuroplasticity via CXCR4 crossinteraction interaction,Scientific Reports,2016 Sep,6(*):1-20
|
SCI論文 |
江智聖(CHIANG CHIH-SHENG)、沈宜珊(Yi-Shang Shen)、劉俊仁(Jun-Jen Liu)、徐偉成(Woei-Cheang Shyu)、陳三元(San-Yuan Chen)*,Synergistic combination of multistage magnetic guidance and optimized ligand density in targeting a nanoplatform for enhanced cancer therapy,Advanced Healthcare Materials,2016 Aug,5(16):2131-2141
|
SCI論文 |
劉詩平(Shih-Ping Liu)*、林振寰、(Shao-Ji Lin)、傅如輝(Ru-Huei Fu)、黃毓銓(Yu-Chuen Huang)、陳世殷(Shih-Yin, Chen)、林欣榮(Shinn-Zong Lin)、許重義(Chung Y. Hsu)、徐偉成(Woei-Cherng Shyu)*,Electrospun Polyacrylonitrile-Based Nanofibers Maintain Embryonic Stem Cell Stemness via TGF-Beta Signaling,Journal of Biomedical Nanotechnology,2016 Apr,12(4):732-742
|
SCI論文 |
吳柏蒼(Bor-Tsang Wu)、(Ming-Chang Chiang)、(Ching-Yi Tasi)、郭家驊(Chia-Hua Kuo)、徐偉成(Woei-Cherng Shyu)、高崇蘭(Chung-Lan Kao)、黃志揚(Chih-Yang Huang)、李信達(Shin-Da Lee)*,Cardiac Fas-Dependent and Mitochondria-Dependent Apoptotic Pathways in a Transgenic Mouse Model of Huntington's Disease.,Cardiovascular Toxicology,2016 Apr,16(2):111-121
|
SCI論文 |
沈明毅(Ming-Yi Shen)、陳芳玉(Fang-Yu Chen)、許菁芳(Jing-Fang Hsu)、傅如輝(Ru-Huei Fu)、張家銘(Chia-Ming Chang)、張志宗(Chiz-Tzung Chang)、劉崇祥(Chung-Hsiang Liu)、吳佳蓉(Wu,Jia-Rong)、李安生(An-Sheng Lee)、(Hua-Chen Chan)、(Joen-Rong Sheu)、林欣榮(Shinn-Zong Lin)、徐偉成(Woei-Cherng Shyu)、(Tatsuya Sawamura)、張坤正(Kuan-Cheng Chang)、許重義(Chung Y. Hsu)*、(Chu-Huang Chen)*,Plasma L5 levels are elevated in ischemic stroke patients and enhance platelet aggregation,BLOOD,2016 Mar,127(10):1336-1345
|
SCI論文 |
(Yu-Ching Chen)、(Sarah Statt)、(Reen Wu)、張顥騰(Hao-Teng Chang)、(Jiunn-Wang Liao)、(Chien-Neng Wang)、徐偉成(Woei-Cherng Shyu)、李珍珍(Chen-Chen Lee)*,High mobility group box 1-induced epithelial mesenchymal transition in human airway epithelial cells,Scientific Reports,2016 Jan,6():18815
|
SCI論文 |
游棟閔(Yu, Tung-Min)、卡拉蘇菲(Kalaiselvi Palanisamy1,)、孫國丁(Kuo-Ting Sun)、戴元基(Yuan-Ji Day)、王怡寬(I-Kuan Wang)、徐偉成(Woei-Cherng Shyu)、陳玉怜(Yuh-Lien Chen)、李繼源(Chi-Yuan Li)*,RANTES mediates kidney ischemia reperfusion injury through a possible role of HIF-1 alpha and LncRNA PRINS,Scientific Reports,2016 Jan,4(6):18424-18424
|
SCI論文 |
陳柏榕、康宜達(Yi-Da Kang)、林振寰、陳三元(San-Yuan Chen)*、謝佳宏(Chia-Hung Hsieh)*、陳右穎(You-Yin Chen)*、江俊緯、李瑋(Wei Lee)、許重義(Chung Y. Hsu)、廖倫德(Lun-De Liao)、范植泰(Chih-Tai Fan)、李夢麟(Meng-Lin Li)、徐偉成(Woei-Cherng Shyu)*,Multitheragnostic Multi-GNRs Crystal-seeded Magnetic Nanoseaurchin for Enhanced In-vivo Mesenchymal Stem Cell Homing, Multimodal Imaging and Stroke Therapy,ADVANCED MATERIALS,2015 Nov,27(41):6488-6495
|
Other論文 |
劉詩平(Shih-Ping Liu)*、(Chien-Yu Hsub)、傅如輝(Ru-Huei Fu)、黃毓銓(Yu-Chuen Huang)、陳世殷(Shih-Yin, Chen)、林欣榮(Shinn-Zong Lin)、徐偉成(Woei-Cherng Shyu),Sambucus williamsii induced embryonic stem cells differentiated into neurons,BioMedicine,2015 Mar,5(1):19-23
|
SCI論文 |
黃志揚(Chih-Yang Huang)、(Shao-Yu Chen)、傅如輝(Ru-Huei Fu)、黃毓銓(Yu-Chuen Huang)、陳世殷(Shih-Yin, Chen)、徐偉成(Woei-Cherng Shyu)、林欣榮(Shinn-Zong Lin)、劉詩平(Shih-Ping Liu)*,Differentiation of Embryonic Stem Cells Into Cardiomyocytes Used to Investigate the Cardioprotective Effect of Salvianolic Acid B Through BNIP3 Involved Pathway,CELL TRANSPLANTATION,2015 Feb,24():
|
SCI論文 |
傅如輝(Ru-Huei Fu)*、蔡佳文(Chia-Wen Tsai)、蔡榮宗(Rong-Tzong Tsai)、劉詩平(Shih-Ping Liu)、詹子民(Tzu-Min Chan)、何于塵(Yu-Chen Ho)、林欣璉(Hsin-Lien Lin)、陳玥米(Yue-Mi Chen,)、洪慧珊(Huey-Shan Hung)、邱紹智(Shao-Chih Chiu)、蔡長海(Chang-Hai Tsai)、(Yu-Chi Wang)、徐偉成(Woei-Cherng Shyu)、林欣榮(Shinn-Zong Lin)*,Irisflorentin Modifies Properties of Mouse Bone Marrow-Derived Dendritic Cells and Reduces the Allergic Contact Hypersensitivity Responses,CELL TRANSPLANTATION,2015 Feb,():
|
SCI論文 |
鄒瑞煌(Ruey-Hwang Chou)、(Lian Chiu)、余永倫(Yung-Luen Yu)*、徐偉成(Woei-Cherng Shyu)*,The Potential Roles of EZH2 in Regenerative Medicine,CELL TRANSPLANTATION,2015 Feb,24(3):313-317
|
SCI論文 |
謝佳宏(Chia-Hung Hsieh)*、(Yu-Jung Lin)、(Chung-Pu Wu)、(Hsu-Tung Lee)、徐偉成(Woei-Cherng Shyu)*、(Chi-Chung Wang)*,Livin contributes to tumor hypoxia-induced resistance to cytotoxic therapies in glioblastoma multiforme,CLINICAL CANCER RESEARCH,2015 Jan,21(2):1-11
|
SCI論文 |
丁大清(Dah-Ching Ding)、(Yu-Hsun Chang)、徐偉成(Woei-Cherng Shyu)、林欣榮(Shinn-Zong Lin)*,Human Umbilical Cord Mesenchymal Stem Cells: A New Era for Stem Cell Therapy,CELL TRANSPLANTATION,2015 Jan,24(3):339-347
|
SCI論文 |
林振寰、屈蓮(Lian Chiu)、李旭東(Hsu-Tung Lee)、江俊緯、劉詩平(Shih-Ping Liu)、Yung-Hsiang(許永祥)、林欣榮(Shinn-Zong Lin)、許重義(Chung Y. Hsu)、謝佳宏(Chia-Hung Hsieh)*、徐偉成(Woei-Cherng Shyu)*,PACAP38/PAC1 Signaling Induces Bone Marrow-Derived Cells Homing to Ischemic Brain,STEM CELLS,2014 Dec,():
|
SCI論文 |
鄭宇容(Cheng, Yu-Jung)、徐偉成(Woei-Cherng Shyu)、鄧薏賢(Yi-Hsien Teng)、藍于琁(Lan Yu Hsuan)、李信達(Shin-Da Lee)*,Antagonistic interaction between Cordyceps sinensis and exercise on protection in fulminant hepatic failure,AMERICAN JOURNAL OF CHINESE MEDICINE,2014 Oct,():
|
SCI論文 |
傅如輝(Ru-Huei Fu)*、(Yu-Chi Wang)、陳昌熙(Chang-Shi Chen)、蔡榮宗(Rong-Tzong Tsai)、劉詩平(Shih-Ping Liu)、張文琳(Wen-Lin Chang)、林欣璉(Hsin-Lien Lin)、呂家慧(Chia-Hui Lu)、魏敬容(Jing-Rong Wei)、王姿雯(Zih-Wan Wang)、徐偉成(Woei-Cherng Shyu)、林欣榮(Shinn-Zong Lin)*,Acetylcorynoline attenuates dopaminergic neuron degeneration and alpha-synuclein aggregation in animal models of Parkinson’s disease,NEUROPHARMACOLOGY,2014 Jul,82():108-120
|
SCI論文 |
傅如輝(Ru-Huei Fu)*、(Yu-Chi Wang)、劉詩平(Shih-Ping Liu)、施彤儒(Ton-Ru Shih)、林欣璉(Hsin-Lien Lin)、陳玥米(Yue-Mi Chen)、宋俊輝(Jiun-Huei Sung)、呂家慧(Chia-Hui Lu)、魏敬容(Jing-Rong Wei)、王姿雯(Zih-Wan Wang)、黃士哲(Shyh-Jer Huang)、蔡長海(Chang-Hai Tsai)、徐偉成(Woei-Cherng Shyu)、林欣榮(Shinn-Zong Lin)*,Decellularization and recellularization technologies in tissue engineering,CELL TRANSPLANTATION,2014 Apr,23(4-5):621-630
|
SCI論文 |
傅如輝(Ru-Huei Fu)*、(Yu-Chi Wang)、劉詩平(Shih-Ping Liu)、施彤儒(Ton-Ru Shih)、林欣璉(Hsin-Lien Lin)、陳玥米(Yue-Mi Chen)、蔡榮宗(Rong-Tzong Tsai)、蔡長海(Chang-Hai Tsai)、徐偉成(Woei-Cherng Shyu)、林欣榮(Shinn-Zong Lin)*,Dryocrassin suppresses immunostimulatory function of dendritic cells and prolongs skin allograft survival,CELL TRANSPLANTATION,2014 Apr,23(4-5):641-656
|
SCI論文 |
鄒瑞煌(Ruey-Hwang Chou)、(Lu CY)、(Wei-Lee)、(Fan JR)、余永倫(Yung-Luen Yu)*、徐偉成(Woei-Cherng Shyu)*,The potential therapeutic applications of olfactory ensheathing cells in regenerative medicine,CELL TRANSPLANTATION,2014 Apr,23(4-5):567-571
|
SCI論文 |
(Chia-Hui Liu)、徐偉成(Woei-Cherng Shyu)、傅如輝(Ru-Huei Fu)、(Shyh-Jer Huang)、(Cheng-Hsuan Chang)、黃毓銓(Yu-Chuen Huang)、陳世殷(Shih-Yin, Chen)、林欣榮(Shinn-Zong Lin)、劉詩平(Shih-Ping Liu)*,Salvianolic Acid B Maintained Stem Cell Pluripotency and Increased Proliferation Rate by Activating Jak2/Stat3 Combined With EGFR-Erk1/2 Pathways,CELL TRANSPLANTATION,2014 Mar,23(0):0-0
|
SCI論文 |
劉詩平(Shih-Ping Liu)、傅如輝(Ru-Huei Fu)、吳東川(Dong Chuan Wu)、(Chien-Yu Hsu)、(Cheng-Hsuan Chang)、李瑋、(Yu-Da Lee)、(Chia Hui Liu)、(Ying-Jiun Chien)、林欣榮(Shinn-Zong Lin)、徐偉成(Woei-Cherng Shyu)*,Mouse induced pluripotent stem cells generated under hypoxic conditions in the absence of viral infection and oncogenic factors and used for ischemic stroke therapy,STEM CELLS AND DEVELOPMENT,2014 Feb,23(4):421-433
|
SCI論文 |
傅如輝(Ru-Huei Fu)*、韓鴻志(Horng-Jyh Harn)、劉詩平(Shih-Ping Liu)、陳昌熙(Chang-Shi Chen)、張文琳(Wen-Lin Chang)、陳玥米(Yue-Mi Chen)、黃靖恩(Jing-En Huang)、李鎔竹(Rong-Jhu Li)、蔡松祐(Sung-Yu Tsai)、洪慧珊(Huey-Shan Hung)、徐偉成(Woei-Cherng Shyu)、林欣榮(Shinn-Zong Lin)、(Yu-Chi Wang)*,n-Butylidenephthalide Protects Against Dopaminergic Neuron Degeneration and alpha-Synuclein Accumulation in Caenorhabditis elegans Models of Parkinson’s Disease,PLoS One,2014 Jan,9(1):e85305
|
SCI論文 |
陳德誠(Der-Cherng Chen)、林欣榮(Shinn-Zong Lin)、(Jia-Rong Fan)、(Chen-Huan Lin)、(Wei Lee, MS)、(Chao Chun Lin)、(Yi Jui Liu)、蔡崇豪(Chon-Haw Tsai)、陳睿正(Jui-Cheng Chen)、周德陽(Der-Yang Cho)、(Chau Chin Lee)、徐偉成(Woei-Cherng Shyu)*,Intracerebral implantation of autologous peripheral blood stem cells in stroke patients: a randomized phase II study.,CELL TRANSPLANTATION,2014 Jan,23(12):1599-1612
|
SCI論文 |
鄭宇容(Cheng, Yu-Jung)、(Shiu-Min Cheng)、(Yi-Hsien Teng)、徐偉成(Woei-Cherng Shyu)、(Hsiu-Ling Chen)、李信達(Shin-Da Lee)*,Cordyceps sinensis Prevents Apoptosis in Mouse Liver with D-Galactosamine/Lipopolysaccharide-Induced Fulminant Hepatic Failure,AMERICAN JOURNAL OF CHINESE MEDICINE,2014 ,42(2):427-441
|
Other論文 |
劉詩平(Shih-Ping Liu)*、傅如輝(Ru-Huei Fu)、黃毓銓(Yu-Chuen Huang)、陳世殷(Shih-Yin, Chen)、徐偉成(Woei-Cherng Shyu)、林欣榮(Shinn-Zong Lin)*,Stem Cell Applications for Parkinson’s Disease,Adaptive Medicine,2013 Dec,5(4):162-170
|
SCI論文 |
李珍珍(Chen-Chen Lee)*、(Yu-Ting Lai)、張顥騰(Hao-Teng Chang)、(Jiunn-Wang Liao)、徐偉成(Woei-Cherng Shyu)、李繼源(Chi-Yuan Li)、(Chien-Neng Wang),Inhibition of high-mobility group box 1 in lung reduced airway inflammation and remodeling in a mouse model of chronic asthma,BIOCHEMICAL PHARMACOLOGY,2013 Oct,86(7):940-949
|
SCI論文 |
張?云(Sunny LY Chang)、鄒瑞煌(Ruey-Hwang Chou)、(HJ-Zeng)、(YH-Lin)、(TY-Chiu)、(DM-Yang)、洪士杰(Shih-Chieh Hung)、賴志河(Chih-Ho Lai)、謝哲宗(Jer-Tsong Hsieh)、徐偉成(Woei-Cherng Shyu)、余永倫(Yung-Luen Yu)*,Downregulation of DAB2IP Promotes Mesenchymal-To-Neuroepithelial Transition and Neuronal Differentiation of Human Mesenchymal Stem Cells,PLoS One,2013 Sep,8(9):e75884
|
SCI論文 |
李信達(Shin-Da Lee)、賴威達(Ted Weita Lai)、林欣榮(Shinn-Zong Lin)、林振寰(Chen-Huan Lin)、許永祥(Yung-Hsiang Hsu)、李繼源(Chi-Yuan Li)、王孝榮(Hsiao-Jung Wang)、李瑋(Wei Lee)、(Ching Yuan Su)、余永倫(Yung-Luen Yu)*、徐偉成(Woei-Cherng Shyu)*,Role of stress‐inducible protein‐1 in recruitment of bone marrow derived cells into the ischemic brains,EMBO Molecular Medicine,2013 Aug,5(2013):1227-1246
|
SCI論文 |
張舒(Shu Zhang)、(Changiz Taghibiglou)、(Kimberly Girling)、(Zhifang Dong)、林欣榮(Shinn-Zong Lin)、(Wei Lee)、徐偉成(Woei-Cherng Shyu)*、王玉田(Yu-Tian Wang)*,Critical Role of Increased PTEN Nuclear Translocation in Excitotoxic and Ischemic Neuronal Injuries,JOURNAL OF NEUROSCIENCE,2013 May,33(18):7997-8008
|
SCI論文 |
林振寰(Chen-Huan Lin)、李旭東(Hus-Tung Lee)、李信達(Shin-Da Lee)、李瑋、卓靚雯(Chin-Wen Chental Cho)、林欣榮(Shinn-Zong Lin)、王孝榮(Hsiao-Jung Wang)、(Hideyuki Okano)、(Ching-Yuan Su)、余永倫(Yung-Luen Yu)、許重義(Chung Y. Hsu)、徐偉成(Woei-Cherng Shyu)*,Role of HIF-1α-activated Epac1 on HSC-mediated neuroplasticity in stroke model,NEUROBIOLOGY OF DISEASE,2013 May,58(2013):76-91
|
SCI論文 |
傅如輝(Ru-Huei Fu)、劉詩平(Shih-Ping Liu)、黃士哲(Huang Shyh-Jer)、陳鴻仁(Hung-Jen Chen)、陳品儒(Pin-Ru Chen)、林雅賢(Ya-Hsien Lin)、何于塵(Yu-Chen Ho)、張文琳(Wen-Lin Chang)、蔡長海(Chang-Hai Tsai)、徐偉成(Woei-Cherng Shyu)、林欣榮(Shinn-Zong Lin)*,Aberrant Alternative Splicing Events in Parkinson’s Disease,CELL TRANSPLANTATION,2013 Apr,22(4):653-661
|
SCI論文 |
黃士哲(Huang Shyh-Jer)、傅如輝(Ru-Huei Fu)、徐偉成(Woei-Cherng Shyu)、劉詩平(Shih-Ping Liu)、鍾國屏(Gwo-Ping Jong)、邱永偉(Yung-Wei Chiu)、吳曉舒(Hsiao-Su Wu)、鄒永恩(Yung-An Tsou)、鄭朝文(Chao-Wen Cheng)、林欣榮(Shinn-Zong Lin)*,Adipose-Derived Stem Cells: Isolation, Characterization and Differentiation Potential.,CELL TRANSPLANTATION,2013 Apr,22(4):701-710
|
SCI論文 |
劉詩平(Shih-Ping Liu)、傅如輝(Ru-Huei Fu)、黃士哲(Huang Shyh-Jer)、黃毓銓(Yu-Chuen Huang)、陳世殷(Shih-Yin, Chen)、張丞軒(Cheng-Hsuan Chang)、劉佳慧(Cha-Hui Liou)、蔡長海(Chang-Hai Tsai)、徐偉成(Woei-Cherng Shyu)、林欣榮(Shinn-Zong Lin)*,Stem Cell Applications in Regenerative Medicine for Neurological Disorders,CELL TRANSPLANTATION,2013 Apr,22(4):631-637
|
SCI論文 |
(Dah-Ching Ding)、(Chen-Huan Lin)、徐偉成(Woei-Cherng Shyu)*、林欣榮(Shinn-Zong Lin)*,Neural Stem Cells and Stroke,CELL TRANSPLANTATION,2013 Apr,22(4):619-630
|
SCI論文 |
余永倫(Yung-Luen Yu)*、鄒瑞煌(Ruey-Hwang Chou)、徐偉成(Woei-Cherng Shyu)、(Hsieh, Shu-Ching)、(Wu, Chen-Shiou)、(Chiang, Shu-Ya)、(Chang, Wei-Jung)、(Chen, Jia-Ni)、(Tseng, Yen-Ju)、(Lin, Yu-Hsuan)、(Lee, Wei)、葉士芃(Su-Peng Yeh)、(Hsu, Jennifer L.)、(Yang, Cheng-Chieh)、洪士杰(Shih-Chieh Hung)、洪明奇(Mien-Chie Hung)*,Smurf2-mediated degradation of EZH2 enhances neuron differentiation and improves functional recovery after ischaemic stroke.,EMBO Molecular Medicine,2013 Apr,5(4):531-547
|
SCI論文 |
傅如輝(Ru-Huei Fu)*、王羽淇(Yu-Chi Wang)、劉詩平(Shih-Ping Liu)、朱清良(Ching-Liang Chu)、蔡榮宗(Rong-Tzong Tsai)、何于塵(Yu-Chen Ho)、張文琳(Wen-Lin Chang)、邱紹智(Shao-Chih Chiu)、韓鴻志(Horng-Jyh Harn)、徐偉成(Woei-Cherng Shyu)、林欣榮(Shinn-Zong Lin)*,Acetylcorynoline Impairs the Maturation of Mouse Bone Marrow-Derived Dendritic Cells via Suppression of IkB Kinase and Mitogen-Activated Protein Kinase Activities,PLoS One,2013 Mar,8(3):e58398
|
SCI論文 |
傅如輝(Ru-Huei Fu)*、劉詩平(Shih-Ping Liu)、朱清良(Ching-Liang Chu)、林雅賢(Ya-Hsien Lin)、何于塵(Yu-Chen Ho)、邱紹智(Shao-Chih Chiu)、林維勇(Wei-Yong Lin)、徐偉成(Woei-Cherng Shyu)、林欣榮(Shinn-Zong Lin)*,Myricetin attenuates lipopolysaccharide-stimulated activation of mouse bone marrow-derived dendritic cells through suppression of IKK/NF-κB and MAPK signaling pathways,JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE,2013 Jan,93(1):76-84
|
SCI論文 |
劉詩平(Shih-Ping Liu)*、韓鴻志(Horng-Jyh Harn)、(Ying-Jiun Chien)、(Cheng-Hsuan Chang)、(Chien-Yu Hsu)、傅如輝(Ru-Huei Fu)、黃毓銓(Yu-Chuen Huang)、陳世殷(Shih-Yin, Chen)、徐偉成(Woei-Cherng Shyu)、林欣榮(Shinn-Zong Lin)*,n-Butylidenephthalide (BP) maintains stem cell pluripotency by activating Jak2/Stat3 pathway and increases the efficiency of iPS cells generation,PLoS One,2012 Sep,7(9):e44024-e44024
|
SCI論文 |
謝佳宏(Chia-Hung Hsieh)*、張顥騰(Hao-Teng Chang)、沈戊忠(Wu-Chung Shen)、徐偉成(Woei-Cherng Shyu)、(Ren-Shyan Liu),Imaging the impact of Nox4 in cycling hypoxia-mediated U87 glioblastoma invasion and infiltration,MOLECULAR IMAGING AND BIOLOGY,2012 Aug,14(4):489-499
|
Other論文 |
陳雅惠(Ya-Huey Chen)、洪明奇(Mien-Chie Hung)*、徐偉成(Woei-Cherng Shyu)*,Role of cancer stem cells in brain tumors,BioMedicine,2012 Jul,2(-):84-89
|
SCI論文 |
丁大清(Dah-Ching Ding)、徐偉成(Woei-Cherng Shyu)、林欣榮(Shinn-Zong Lin)、(Hwan-Wun Liu)、(Shih-Hwa Chiou)、(Tang-Yuan Chu)*,Human Umbilical Cord Mesenchymal Stem Cells Support Nontumorigenic Expansion of Human Embryonic Stem Cells,CELL TRANSPLANTATION,2012 Jul,21(0):1515-1527
|
SCI論文 |
盧大宇(Lu Dah-Yuu)、陳惠珍(Hui-Chen Chen)、(MS Yang)、徐媛曼(Yuan-Man Hsu)、(HJ Lin)、湯智昕(Tang Chih-Hsin)、李哲欣(Lee, Che-Hsin)、(Cheng-Kuo Lai)、(Chun-Jung Lin)、徐偉成(Woei-Cherng Shyu)、(FY Lin)、賴志河(Chih-Ho Lai)*,Ceramide and TLR4 are mobilized into membrane rafts in response to Helicobacter pylori infection in gastric epithelial cells,INFECTION AND IMMUNITY,2012 Jun,80(5):1823-1833
|
SCI論文 |
賴威達(Ted Weita Lai)、林欣榮(Shinn-Zong Lin)、(Hsu-Tung Lee)、(Jia-Rong Fan)、(Yung-Hsiang Hsu)、王孝榮(Hsiao-Jung Wang)、余永倫(Yung-Luen Yu)、徐偉成(Woei-Cherng Shyu)*,HIF-1α binding to the Epac1 promoter recruits hematopoietic stem cells to the ischemic brain following stroke,Journal of Molecular Cell Biology,2012 Jun,4(3):184-187
|
SCI論文 |
黃匯淳(Hui-Chun Huang)、吳昱?(Yu-Chin Wu)、施麗雲(Lee-Yung Shih)、羅偉忠(Lo Woei Chung)、蔡崇豪(Chon-Haw Tsai)*、徐偉成(Woei-Cherng Shyu)*,Reversible abnormal functional neuroimaging presentations in polycythemia vera with chorea,JOURNAL OF NEUROLOGY,2011 Nov,258(11):2054-2057
|
SCI論文 |
謝佳宏(Chia-Hung Hsieh)*、徐偉成(Woei-Cherng Shyu)、(Chien-Yi Chiang)、(Jung-Wen Kuo)、沈戊忠(Wu-Chung Shen)、(Ren-Shyan Liu),NADPH Oxidase Subunit 4-mediated Reactive Oxygen Species Contribute to Cycling Hypoxia-promoted Tumor Progression in Glioblastoma Multiforme,PLoS One,2011 Sep,6(9):e23945
|
SCI論文 |
賴威達(Ted Weita Lai)、徐偉成(Woei-Cherng Shyu)、王玉田(Yu-Tian Wang)*,Stroke intervention pathways: NMDA receptors and beyond,TRENDS IN MOLECULAR MEDICINE,2011 May,17(5):266-275
|
SCI論文 |
傅如輝(Ru-Huei Fu)、(Yu-Chi Wang)、劉詩平(Shih-Ping Liu)、黃競懋(Chin-Mao Huang)、康蕓涵(Yun-Han Kang)、蔡長海(Chang-Hai Tsai)、徐偉成(Woei-Cherng Shyu)*、林欣榮(Shinn-Zong Lin)*,Differentiation of Stem Cells: Strategies for Modifying Surface Biomaterials,CELL TRANSPLANTATION,2011 Mar,20(1):37-47
|
SCI論文 |
余永倫(Yung-Luen Yu)*、鄒瑞煌(Ruey-Hwang Chou)、(Ling-Tzu Chen)、徐偉成(Woei-Cherng Shyu)、(Su-Ching Hsieh)、(Chen-Shiou Wu)、(Hong-Jie Zeng)、葉士芃(Su-Peng Yeh)、(De-Ming Yang)、洪士杰(Shih-Chieh Hung)、洪明奇(Mien-Chie Hung)*,EZH2 regulates neuronal differentiation of mesenchymal stem cells through PIP5K1C-dependent calcium signaling,JOURNAL OF BIOLOGICAL CHEMISTRY,2011 Mar,286(11):9657-9667
|
SCI論文 |
劉詩平(Shih-Ping Liu)、傅如輝(Ru-Huei Fu)、黃毓銓(Yu-Chuen Huang)、陳世殷(Shih-Yin, Chen)、簡瀅珺、許千祐、蔡長海(Chang-Hai Tsai)、徐偉成(Woei-Cherng Shyu)*、林欣榮(Shinn-Zong Lin)*,Induced Pluripotent Stem (iPS) Cell Research Overview,CELL TRANSPLANTATION,2011 Mar,20(1):15-19
|
SCI論文 |
傅如輝(Ru-Huei Fu)*、韓鴻志(Horng-Jyh Harn)、朱清良(Ching-Liang Chu)、黃競懋(Chin-Mao Huang)、劉詩平(Shih-Ping Liu)、王羽淇(Yu-Chi Wang)、林雅賢(Ya-Hsien Lin)、徐偉成(Woei-Cherng Shyu)、林欣榮(Shinn-Zong Lin),Lipopolysaccharide-stimulated activation of murine DC2.4 cells is attenuated by n-butylidenephthalide through suppression of the NF-κB pathway,BIOTECHNOLOGY LETTERS,2011 Jan,33(5):903-910
|
SCI論文 |
丁大清(Ding DC)、徐偉成(Woei-Cherng Shyu)*、林欣榮(Shinn-Zong Lin)*,Mesenchymal stem cells,CELL TRANSPLANTATION,2011 Jan,20(1):5-14
|
SCI論文 |
陳世殷(Shih-Yin, Chen)、黃毓銓(Yu-Chuen Huang)、劉詩平(Shih-Ping Liu)、蔡輔仁(Fuu-Jen Tsai)、徐偉成(Woei-Cherng Shyu)*、林欣榮(Shinn-Zong Lin)*,An Overview of Concepts for Cancer Stem Cells,CELL TRANSPLANTATION,2011 ,20(1):113-120
|
SCI論文 |
謝佳宏(Chia-Hung Hsieh)*、(CHENG-HUNG LEE)、梁基安(Ji-An Liang)、游浚彥(Chun-Yen Yu)、徐偉成(Woei-Cherng Shyu),Cycling hypoxia increases U87 glioma cell radioresistance via ROS induced higher and long-term HIF-1 signal transduction activity.,ONCOLOGY REPORTS,2010 Dec,24(6):1629-1636.
|
SCI論文 |
劉詩平(Shih-Ping Liu)、丁大清(Dah-Ching Ding)、(Hsu-Tung Lee)、陳德誠(Der-Cherng Chen)、王孝榮(Hsiao-Jung Wang)、林欣榮(Shinn-Zong Lin)*、徐偉成(Woei-Cherng Shyu)*,Non-senescent Hsp27-Upregulated MSCs Implantation Promote Neuroplasticity in Stroke Model,CELL TRANSPLANTATION,2010 Oct,19(10):1261-1279
|
SCI論文 |
陳卓昇(Jwo-Sheng Chen)、王慧如、張文正、(Chin-Ci Jao)、吳柏蒼(Bor-Tsang Wu)*、徐偉成(Woei-Cherng Shyu)*、李信達(Shin-Da Lee)*,Altered nitroxidergic and NMDA receptor-mediated modulation mediated heart rate in obese Zucker rats,HYPERTENSION RESEARCH,2010 Sep,33():
|
SCI論文 |
羅婉瑜(Wan-Yu Lo)、蔡輔仁(Fuu-Jen Tsai)、劉崇祥(Chung-Hsiang Liu)、唐娜櫻(Nou-Ying Tang)、蘇珊玉(Shan-Yu Su)、林欣榮(Shinn-Zong Lin)、陳春忠(CHUN-CHUNG CHEN)、徐偉成(Woei-Cherng Shyu)*、謝慶良(Ching-Liang Hsieh)*,Uncaria rhynchophylla Upregulates the Expression of MIF and Cyclophilin A in Kainic Acid-Induced Epilepsy Rats: A Proteomic Analysis,AMERICAN JOURNAL OF CHINESE MEDICINE,2010 Jul,38(4):745-759
|
SCI論文 |
唐娜櫻(Nou-Ying Tang)、劉崇祥(Chung-Hsiang Liu)、蘇珊玉(Shan-Yu Su)、詹雅閔(Ya-Min Jan)、謝慶竇(Ching-Tou, Hsieh)、程錦宜(Chin-Yi Cheng)、徐偉成(Woei-Cherng Shyu)、謝慶良(Ching-Liang Hsieh)*,Uncaria rhyncholylla (Miq) Jack Plays a Role in Neuronal Protection in Kainic Acid-Treated Rats,AMERICAN JOURNAL OF CHINESE MEDICINE,2010 Apr,38(2):251-263
|
SCI論文 |
劉詩平(Shih-Ping Liu)、李信達(Shin-Da Lee)、(Hsu-Tung Lee)、劉德模(Demeral David Liu)、王孝榮(Hsiao-Jung Wang)、(Ren-Shyan Liu)、林欣榮(Shinn-Zong Lin)、徐偉成(Woei-Cherng Shyu)*,Granulocyte Colony-Stimulating Factor Activating HIF-1a Acts Synergistically with Erythropoietin to Promote Tissue Plasticity,PLoS One,2010 Apr,5(4):e10093-1-13
|
SCI論文 |
劉詩平(Shih-Ping Liu)、傅如輝(Ru-Huei Fu)、尤慧(Hsiu-Hui Yu)、李國瑋(Kuo-Wei Li)、蔡長海(Chang-Hai Tsai)、徐偉成(Woei-Cherng Shyu)*、林欣榮(Shinn-Zong Lin)*,MicroRNAs Regulation Modulated Self-Renewal and Lineage Differentiation of Stem Cells,CELL TRANSPLANTATION,2009 Dec,18(9):1039-1045
|
SCI論文 |
傅如輝(Ru-Huei Fu)、劉詩平(Shih-Ping Liu)、歐振偉(Chen-Wei Ou)、尤綉慧(Hsiu-Hui Yu)、李國偉(Kuo-Wei Li)、蔡長海(Chang-Hai Tsai)、徐偉成(Woei-Cherng Shyu)*、林欣榮(Shinn-Zong Lin)*,Alternative Splicing Modulates Stem Cell Differentiation,CELL TRANSPLANTATION,2009 Dec,18(9):1029-1038
|
SCI論文 |
洪慧珊(Huey-Shan Hung)、徐偉成(Woei-Cherng Shyu)、蔡長海(Chang-Hai Tsai)、(Hsu SH)、林欣榮(Shinn-Zong Lin)*,Transplantation of endothelial progenitor cells as therapeutics for cardiovascular diseases,CELL TRANSPLANTATION,2009 Dec,18(9):1003-1012
|
SCI論文 |
(Yih-Jimg Tang)、楊家欣(Yang Jai-Sing)、林錦芬(Lin, Chin-Fen)、徐偉成(Woei-Cherng Shyu)、(Minoru Tsuzuki)、(Chi-Cheng Lu)、陳玉芳(Yuh-Fung Chen)*、賴光啟(Kuang-Chi Lai)*,Houttuynia cordata Thunb extract induces apoptosis through mitochondrial-dependent pathway in HT-29 human colon adenocarcinoma cells,ONCOLOGY REPORTS,2009 Nov,22(5):1051-1056
|
SCI論文 |
羅婉瑜(Wan-Yu Lo)、蔡輔仁(Fuu-Jen Tsai)、劉崇祥(Chung-Hsiang Liu)、唐娜櫻(Nou-Ying Tang)、蘇珊玉(Shan-Yu Su)、林欣榮(Shinn-Zong Lin)、陳春忠(CHUN-CHUNG CHEN)、徐偉成(Woei-Cherng Shyu)*、謝慶良(Ching-Liang Hsieh)*,Uncaria rhyncholylla up-regulates the expression of MIF and cyclophilin A in Kainic acid-induced epilepsy rats: a proteomic analysis,AMERICAN JOURNAL OF CHINESE MEDICINE,2009 Nov,38(4):745-759
|
SCI論文 |
徐偉成(Woei-Cherng Shyu)、(Kuo-wei Li)、(Hsiao Fen Peng)、林欣榮(Shinn-Zong Lin)、(Ren Shyan Liu)、(Hsiao Jung Wang)、(Ching Yuan Su)、(Yih Jing Lee)、李鴻(HUNG LI)*,Induction of GAP-43 Modulates Neuroplasticity in PBSC (CD34+) Implanted-Parkinson’s Model,JOURNAL OF NEUROSCIENCE RESEARCH,2009 Feb,(87):2020-2033
|
SCI論文 |
徐偉成(Woei-Cherng Shyu)、劉德模(Demeral David Liu)*、林欣榮(Shinn-Zong Lin)、李雯雯(Wen-Wen Li)、蘇靜媛(Cing-Yun Su)、張殷誠(Ying-Chen Chang)、王孝榮(Hsiao-Jung Wang)、王興萬(Hsing-Won Wang)、蔡長海(Chang-Hai Tsai)、李鴻(HUNG LI)*,Implantation of olfactory ensheathing cells promotes neuroplasticity in murine models of stroke,JOURNAL OF CLINICAL INVESTIGATION,2008 Jul,118(7):2482-2495
|
SCI論文 |
徐偉成(Woei-Cherng Shyu)、林欣榮(Shinn-Zong Lin)、顏寶勝(Pao-Sheng Yen)、蘇靜媛(Ching-Yuan Su)、陳德誠(Der-Cherng Chen)、王孝榮(Hsiao-Jung Wang)、李鴻(hung li),Stromal Cell-Derived factor-1 alpha promotes neuroprotection angiogenesis, and mobilization/homing of bone marrow-derived cells in Stroke rats,JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS,2008 Feb,324(2):834-849
|
SCI論文 |
徐偉成(Woei-Cherng Shyu)、林欣榮(Shinn-Zong Lin)、(Ming-Fu Chiang)、陳德誠(Der-Cherng Chen)、(Ching-Yuan Su)、王孝榮(Hsiao-Jung Wang)、(Ren-Shyan Liu)、蔡長海(Chang-Hai Tsai)、李鴻(Hung Li)*,Secretoneurin promotes neuroprotection and neuronal plasticity via the Jak2/Stat3 pathway in murine models of stroke,JOURNAL OF CLINICAL INVESTIGATION,2008 Jan,118(1):133-148
|
SCI論文 |
丁大清(Dah-Ching Ding)、徐偉成、(Ming-Fu Chiang)、林欣榮(Shinn-Zong Lin)、(Ying-Chen Chang)、(Hsiao-Jung Wang)、(Ching-Yuan Su)、李鴻(Hung Li)*,Enhancement of neuroplasticity through upregulation of β1-integrin in human umbilical cord-derived stromal cell implanted stroke model.,NEUROBIOLOGY OF DISEASE,2007 Sep,(27):339-353
|
SCI論文 |
(Raymond Yen-Yu Lo)、徐偉成、林欣榮(Shinn-Zong Lin)、王孝榮(Hsiao-Jung Wang)、(Shun-Sheng Chen)、李鴻(Hung Li)*,New molecular insights into cellular survival and stress responses : neuroprotective role of cellular prion protein (PrPc).,MOLECULAR NEUROBIOLOGY,2007 Jun,35(0):236-244
|
SCI論文 |
(Hsin YL)、(Chuang MF)、徐偉成、(Lin CY)、(Chen YH,)、(Harnod T),Adult-onset autosomal dominant myoclonic epilepsy: Report of a family with an overlooked epileptic syndrome,SEIZURE-EUROPEAN JOURNAL OF EPILEPSY,2007 May,16(2):160-165
|
SCI論文 |
(Ying-Chao Chang)、徐偉成、林欣榮(Shinn-Zong Lin)、李鴻(Hung Li),Regenerative therapy for stroke.,CELL TRANSPLANTATION,2007 Apr,16(2):171-181
|
SCI論文 |
(Ding DC,)、徐偉成、林欣榮(Shinn-Zong Lin)、李鴻(Hung Li)*,The role of endothelial progenitor cells in ischemic cerebral and heart disease.,CELL TRANSPLANTATION,2007 Mar,16(3):273-284
|
SCI論文 |
徐偉成、(Chie-Pein Chen)、林欣榮(Shinn-Zong Lin)、(Yih-Jing Lee)、李鴻(Hung Li),Efficient tracking of non-iron-labeled mesenchymal stem cells with serial MRI in chronic stroke rats.,STROKE,2007 Feb,38(2):367-374
|
SCI論文 |
劉德模(Demeral David Liu)、徐偉成、林欣榮(Shinn-Zong Lin)*,Stem cell therapy in stroke: strategies in basic study and clinical application.,ACTA NEUROCHIRURGICA,2006 Dec,Supplement(99):137-139
|
SCI論文 |
丁大清(Ding D.C)、徐偉成(Woei-Cherng Shyu)、林欣榮(Shinn-Zong Lin)、李鴻(Hung Li)*,Current concepts in adult stem cell therapy for stroke. Current Medicinal Chemistry,CURRENT MEDICINAL CHEMISTRY,2006 Dec,13(29):3565-3574
|
SCI論文 |
(Lo YY)、徐偉成、李鴻(Hung Li),Long-duration sCJD with PRNP codon 129 methionine homozygosity and cerebral cortical plaque.,NEUROLOGY,2006 Jun,66(12):1944-1945
|
SCI論文 |
徐偉成、林欣榮(Shinn-Zong Lin)、(Ming-Fu Chiang)、(Ching-Yuan Su)、李鴻(Hung Li)*,Intracerebral peripheral blood stem cell (CD34+) implantation induces neuroplasticity by enhancing β1-integrin-mediated angiogenesis in chronic stroke rats.,JOURNAL OF NEUROSCIENCE,2006 May,26(13):3444-3453
|
SCI論文 |
(Peterus Thajeb)*、(Jon-Son Kuo)、徐偉成、林欣榮(Shinn-Zong Lin),Neuroprotection with methylaminochroman and lazaroid of embryonic ventral mesencephalic tegmental dopaminergic neurons in cold storage.,JOURNAL OF CLINICAL NEUROSCIENCE,2006 May,13(4):467-470
|
SCI論文 |
徐偉成、林欣榮(Shinn-Zong Lin)、(Chau-Chin Lee)、劉德模(Demeral David Liu)、李鴻(Hung Li)*,Granulocyte colony-stimulating factor for acute ischemic stroke: a randomized controlled trial,CANADIAN MEDICAL ASSOCIATION JOURNAL,2006 Mar,174(7):927-933
|
SCI論文 |
徐偉成、林欣榮(Shinn-Zong Lin)、(Yang HI)、(Pang CY)、(Yen PS)、李鴻(Hung Li)*,Homing genes, cell therapy and stroke.,FRONTIERS IN BIOSCIENCE,2006 Jan,11(1):899-907
|
SCI論文 |
(Wei-Hsing Lee)、(Chau-Chin Lee)、徐偉成、(Pau-Nyen Chong)、林欣榮(Shinn-Zong Lin),Hyperintense putaminal rim sign is not a hallmark of multiple system attophy at 3T,,AMERICAN JOURNAL OF NEURORADIOLOGY,2005 Oct,26(0):2238-2242
|
SCI論文 |
徐偉成、林欣榮(Shinn-Zong Lin)、(Yang HI)、(Pang CY)、(Yen PS)、李鴻(Hung Li)*,Over-expression of PrPC by adenovirus-mediated gene targeting reduces ischemic injury in a stroke rat model.,JOURNAL OF NEUROSCIENCE,2005 Aug,25(39):8967-8977
|
SCI論文 |
徐偉成、(C.-P.Chen)、(K.Saeki)、(A.Kubosaki)、(Y.Matusmoto)、(T.Onodera)、(D.-C.Ding)、(M.-F. Chiang)、(Y.-J.Lee)、林欣榮(Shinn-Zong Lin)、李鴻(Hung Li)*,Hypoglycemia Enhances the Expression of Prion Protein and Heat- Shock Protein 70 in a Mouse Neuroblastoma Cell Line.,JOURNAL OF NEUROSCIENCE RESEARCH,2005 Jun,80(6):887-894
|
SCI論文 |
徐偉成、林欣榮(Shinn-Zong Lin)、(Ming-Fu Chiang)、(Cheng-Yoong Pang)、(Shin-Yuan Chen)、(Yue-Loong Hsin)、(Peterus Thajeb)、(Yih-Jing Lee)、李鴻(Hung Li)*,Early-onset Parkinson's disease in a Chinese population 99mTc-TRODAT-1 SPECT, Parkin gene analysis and clinical study.,PARKINSONISM & RELATED DISORDERS,2005 May,11(3):173-180
|
SCI論文 |
徐偉成、林欣榮(Shinn-Zong Lin)*,Letter regarding article “Functional recovery of stroke rats induced by Granulocyte-Colony Stimulating Factor stimulated stem cells.,CIRCULATION,2005 May,111(19):e297-e298
|
SCI論文 |
徐偉成、林欣榮(Shinn-Zong Lin)、(Hui-I Yang)、(Yi-Shiuan Tzeng)、(Cheng-Yoong Pang)、(Poa-Sheng Yen)、李鴻(Hung Li)*,Functional Recovery of Stroke Rats Induced by Granulocyte Colony-Stimulating Factor-Stimulated Stem Cells.,CIRCULATION,2004 Sep,110(13):1847-1854
|
SCI論文 |
徐偉成、林欣榮(Shinn-Zong Lin)、(Ming-Fu Chiang)、(Hui-I Yang)、(Peterus Thajeb)、李鴻(Hung Li)*,Neuregulin-1 reduces ischemia-induced brain damage in rats.,NEUROBIOLOGY OF AGING,2004 Aug,25(7):935-944
|
SCI論文 |
徐偉成、林欣榮(Shinn-Zong Lin)、(Keiichi Saeki)、(Astsutaka Kubosaki)、(Yoshitsugu Matsumoto)、(Takashi Onodera)、(Ming-Fu Chiang)、(Peterus Thajeb)、李鴻(Hung Li)*,Hyperbaric oxygen enhances the expression of prion protein and heat shock protein 70 in a mouse neuroblastoma cell line.,CELLULAR AND MOLECULAR NEUROBIOLOGY,2004 Apr,24(2):257-268
|
|
研討會論文/Conference Papers (發表主題或論文名稱,研討會名稱,演講地點,研討會期間,受邀演講題目)
|
1﹒ |
Natural-compound-derived multifunctional nanomedicines for cancer theranostics,ISOMRM 2023年第六屆台灣國際再生醫學材料應用研討會,新北市淡水福容大飯店-淡水漁人碼頭舉辦,2023.8.31 ~ 2023.9.3,
|
2﹒ |
Inherently therapeutic fucoidan-based nanoparticles: from combination immunotherapy and advanced cell delivery to translational medicine,2023臺灣奈米生醫學會年會暨國際研討會,台中長榮桂冠酒店,2023.7.21 ~ 2023.7.22,
|
3﹒ |
,The 2nd CMU-HU JOINT SYMPOSIUM,中國醫藥大學,2019.9.3 ~ 2019.9.3,Evaluate the treatment efficacy of miRNA and TRAIL dual expression vector transfected mesenchymal stem cells on glioblastoma and breast cancer
|
4﹒ |
Licochalcone A Prevents Neuroblastoma Cells from Rotenone-Induced Apoptosis via the PI3K/Akt/GSK-3β/CREB Signaling Pathway,2019 International Research Forum on Biology and Medical Science,Kaohsiung,2019.8.22 ~ 2019.8.25,
|
5﹒ |
,2 0 1 6 年幹細胞研究與細胞治療新知研討會暨 臺灣幹細胞醫學會第十二屆年會,台灣台中,2016.5.14 ~ 2016.5.16,OLFACTORY STEM CELLS IN STROKE TREATMENT
|
6﹒ |
The novel application of Cordycepin to maintiant the stem cell pluripotency and increase iPS generation efficiency,2015 ISSCR,瑞典斯德哥爾摩,2015.6.24 ~ 2015.6.27,
|
7﹒ |
Longitudinal perfusion change after stem cell implantation in Chronic stroke patients,中華民國放射線醫學會第二十八屆第三次會員大會暨第六十四次學術研討會,台灣台北,2015.3.21 ~ 2015.3.22,
|
8﹒ |
A novel application of Cordycepin (Cordyceps sinensis extract): maintaining stem cell pluripotency and improving iPS generation efficiency,International Conference on Cellular and Molecular Biology 2014,法國巴黎,2014.4.28 ~ 2014.4.29,
|
9﹒ |
THE NOVEL IPS CELLS GENERATED UNDER HYPOXIC CONDITIONS IN THE ABSENCE OF VIRAL INFECTION AND ONCOGENIC FACTORS AND USED FOR THE ISCHEMIC STROKE THERAPY,The 2013 stem cell event triology,英國倫敦,2013.6.4 ~ 2013.6.6,THE NOVEL IPS CELLS GENERATED UNDER HYPOXIC CONDITIONS IN THE ABSENCE OF VIRAL INFECTION AND ONCOGENIC FACTORS AND USED FOR THE ISCHEMIC STROKE THERAPY
|
10﹒ |
The novel iPS cells generated under hypoxic conditions in the absence of viral infection and oncogenic factors and used for the ischemic stroke therapy,The 2013 stem cell event trilogy,英國倫敦,2013.6.4 ~ 2013.6.6,
|
11﹒ |
Acetylcorynoline, a potential anti-parkinsonian phytocompound in pharmacological and transgenic Caenorhabditis elegans models of Parkinson's disease,第六屆泛太平洋國際幹細胞及癌症研究研討會,Sheraton Hsinchu Hotel,2013.4.13 ~ 2013.4.15,
|
12﹒ |
Acetylcorynoline Impairs the Maturation of Mouse Bone Marrow-Derived Dendritic Cells,JST-CREST International Symposium,Hitotsubashi Memorial Hall, Tokyo, Japan,2013.2.12 ~ 2013.2.13,
|
13﹒ |
Two years results of phase I clinical trial for chronic stroke patients treated with autogenous CD 34+ stem cells transplantation and preliminary results of phase II study,台灣神經外科醫學會第十ㄧ屆第ㄧ次會員大會暨學術研討會,台中,2012.11.30 ~ 2012.12.1,
|
14﹒ |
Oxymatrin, a potential anti-Parkinsonian phytocompound in transgenic and pharmacological Caenorhabditis elegans models of Parkinson's disease,5th East Asia C. elegans Meeting,Chientan Overseas Youth Activity Center, Taipei, Taiwan,2012.6.27 ~ 2012.6.30,
|
15﹒ |
Longitudinal perfusion change after intracranial stem cell implantation in chronic,ISMRM 20th Annual Meeting & Exhibition,Melbourne, Australia,2012.5.5 ~ 2012.5.11,
|
16﹒ |
Salvianolic acid B maintains stem cell pluripotency and increase it’s proliferation rate by activating Jak2/Stat3 and the EGFR-ERK1/2 pathways.,第27屆生物醫學聯合學術年會,國防醫學院,2012.3.17 ~ 2012.3.18,
|
17﹒ |
Cordycepin maintained the pluripotency of ES and iPS cells by activating ECM and Jak2-Stat3 signalin,2011 FAOPS Satellite Symposium on Alternative (Herbal) Medicine,中國醫藥大學,2011.9.10 ~ 2011.9.10,
|
18﹒ |
Effect of Motion and Eddy-Current Correction on the Reproducibility of Corticospinal Diffusion Tensor Tractography in Normal Subjects and Stroke Patients,ASNR 49th Annual Meeting & the Foundation of the ASNR Symposium 2011,SEATTLE,USA,2011.6.4 ~ 2011.6.9,
|
19﹒ |
Longitudinal Tracking of Intracerebral Implanted Stem Cells by R2* Relaxivity in Chronic Stroke Patients,ASNR 49th Annual Meeting & the Foundation of the ASNR Symposium 2011,SEATTLE, USA,2011.6.4 ~ 2011.6.9,
|
20﹒ |
N-Butylidenephthalide (BP) maintained the pluripotency of embryonic stem and induced pluripotent stem cells by activating Jak2/Stat3 pathway,International Society for Stem Cell Research 9th Annual Meeting,Toronto, Ontario Canada,2011.6.15 ~ 2011.6.18,
|
21﹒ |
Study of alternative splicing events of TPD52L2 in glioblastoma,RNA 2011 Sixteenth Annual Meeting of the RNA Society,The Kyoto International Conference Center, Japan,2011.6.14 ~ 2011.6.18,
|
22﹒ |
Abnormal Neuroimaging Presentations in Polycythemia vera with Chorea,The 15th International Congress of Parkinson’s Disease and Movement Disorders,Toronto, Canada,2011.6.5 ~ 2011.6.9,
|
23﹒ |
Characterization and functional study of CPAP-associated protein-1(CPAPAP-1) in NF-κB-mediated transcriptional activation,IMMUNOLOGY 2011, the 98th AAI Annual Meeting,Moscone Center, San Francisco, CA, USA,2011.5.13 ~ 2011.5.17,
|
24﹒ |
,XXVth International Symposium on Cerebral Blood Flow, Metabolism, & Function, and Xth International,西班牙巴塞隆納,2011.5.24 ~ 2011.5.28,Stem cell therapy in stable stroke patients
|
25﹒ |
真性紅血球增多症所致舞蹈症Polycythemia chorea: a case report,2011年神經醫學聯合學術研討會,台北醫學大學,2011.4.30 ~ 2011.5.1,
|
26﹒ |
EZH2 Regulates Neuronal Differentiation of Mesenchymal Stem Cells through PIP5K1C-dependent Calcium Signaling,The 4th Pan Pacific Symposium on Stem Cells and Cancer Researches,The Evergreen Laurel Hotel, Taichung, Taiwan,2011.4.15 ~ 2011.4.18,
|
27﹒ |
POLYCYTHEMIA CHOREA: Novel neuroimaging interpretation,第三屆亞太巴金森症暨動作障礙學術研討會,台北國際會議中心,2011.3.25 ~ 2011.3.27,
|
28﹒ |
Butylidenephthalide (BP) maintained the pluripotency of iPS cells by activating Jak-STAT3 pathway,第26屆生物醫學聯合學術年會,國防醫學院,2011.3.19 ~ 2011.3.20,
|
29﹒ |
,2010細胞暨組織產品及人體器官保存庫之台北國際研討會,台大醫院國際會議中心,2010.10.13 ~ 2010.10.14,CD34 stem cell intracranial transplantation in treating stable stroke patients: a randomized, controlled phase II trial
|
30﹒ |
,World Forum on Cerebral Blood Flow Metabolism & Function,日本京都,2010.10.18 ~ 2010.10.20,Stem cell therapy in chronic stroke patients-Phase II trial
|
31﹒ |
,2010第二屆國際幹細胞與再生醫學研討會,陽明大學國際會議中心,2010.9.24 ~ 2010.9.25,CD34 stem cell intracranial transplantation in treating stable stroke patients a randomized, controlled phase II trial
|
32﹒ |
,第一屆第二次台灣立體定位功能性神經外科及放射手術學會年會 暨第四屆亞洲區加馬刀研討會,台北晶華酒店,2010.9.18 ~ 2010.9.19,CD34 stem cell intracranial transplantation in treating stable stroke patients: a randomized, controlled phase II trial
|
33﹒ |
,2010 The 7th Asia Pacific Symposium on Neural Regeneration,Yonsei University, Seoul , Korea,2010.9.17 ~ 2010.9.18,CD34 stem cell intracranial transplantation in treating stable stroke patients: a randomized, controlled phase II trial
|
34﹒ |
,第二屆海峽兩岸暨國際神經外科論壇,中國廣州,2010.9.25 ~ 2010.9.26,CD34 stem cell intracranial transplantation in treating stable stroke patients a randomized, controlled phase II trial
|
35﹒ |
,第一屆台灣醫學美容、微整形、抗衰老及生髮醫學聯合學術論壇,台灣台北財團法人張榮發基金會10樓國際會議中心,2010.6.20 ~ 2010.6.20,
|
36﹒ |
,The 8th Annual International Cord Blood Transplantation Symposium,美國舊金山,2010.6.3 ~ 2010.6.5,
|
37﹒ |
,2010年國防醫學院第八屆世界校友會暨國際生物醫學研究及管理會議,香港尖沙嘴龍堡國際賓館,2010.6.5 ~ 2010.6.7,A clinical trial of the treatment of stroke with cord blood stem cells
|
38﹒ |
,國際神經修復學會第三屆年會(3rd International Association of Neurorestoratology),中國北京,2010.4.23 ~ 2010.4.25,CD34 stem cell implantation enables the regeneration of the corticospinal tract in the chronic stroke patients
|
39﹒ |
,幹細胞及神經損傷之再生醫療國際研討會,花蓮慈濟醫院協力樓一樓協力講堂,2010.4.22 ~ 2010.4.24,CD34 stem cell implantation enables the regeneration of the corticospinal tract in the chronic strok
|
40﹒ |
,第三屆泛太平洋國際幹細胞研討會(3rd Pan Pacific Symposium on Stem Cells Research 2010),台中長榮桂冠酒店,2010.4.16 ~ 2010.4.19,CD34 stem cell implantation enables the regeneration of the corticospinal tract in the chronic stroke patients
|
41﹒ |
,17th Annual Conference of the American Society for Neural Therapy & Repair,美國加州佛羅里達,2010.4.29 ~ 2010.5.1,Intracerebral Implantation of Autologous Peripheral Blood Stem Cells _CD34_ in Old Ischemic Stroke Patients
|
42﹒ |
使用自體幹細胞治療慢性中風病患第一期臨床試驗兩年結果報告及第二期初步結果報告,台灣神經外科醫學會2009年會暨學術研討會,台北榮總,2009.12.5 ~ 2009.12.6,
|
43﹒ |
,國際外科學會中華民國總會專題演講-外科學籍醫療人文最新發展討論會,台北民總醫院致德樓第十會議室,2009.11.1 ~ 2009.11.1,Stem cells therapy in neurological diseases
|
44﹒ |
How Stem Cells Make the Corticospinal Tract Regenerated in Stroke Patients,The XIV World Congress of Neurological Surgery of the World Federation of Neurosurgical Societies (W,美國波士頓,2009.8.30 ~ 2009.9.4,
|
45﹒ |
,2st Pan Pacific Symposium on Stem Cells Research 2009,中國醫藥大學,2009.4.11 ~ 2009.4.12,
|
46﹒ |
,2009 IMEC-NSoC-TWEMBA Workshop on Bio-medical Electronics,交通大學光復校區電子資訊研究大樓國際會議廳,2009.3.26 ~ 2009.3.26,Stem Cell Therapy in Stroke
|
47﹒ |
,2009 IMEC-NSoC-TWEMBA Workshop on Bio-medical Electronics,國立交通大學國際會議中心,2009.3.26 ~ 2009.3.26,Stem cells therapy in stroke
|
48﹒ |
,Asian Australasian Society of Stereotactic and Functional Neurosurgery (AASSFN),香港威爾斯親王醫院深造大樓,2009.1.8 ~ 2009.1.10,How Stem Cells Make the Corticospinal Tract
|
49﹒ |
,中華民國中西結合神經醫學會第二屆第三次會員大會暨學術研討會,國立台灣師範大學綜合大樓5樓國際會議廳,2009.1.11 ~ 2009.1.11,How stem cells make corticospinal tract regenerated in stroke patients
|
50﹒ |
,Asian Australasian Society of Stereotactic and Functional Neurosurgery,香港威爾斯親王醫院,2009.1.8 ~ 2009.1.10,How stem cells make the corticospinal tract regenerated in stroke
|
51﹒ |
SDF-1因子促進中風老鼠骨髓幹細胞移行以達神經保護及血管新生機制之探討,台灣神經外科醫學會2008年會暨學術研討會,義大,2008.11.29 ~ 2008.11.30,
|
52﹒ |
,台灣腦中風學會第八屆第一次會員大會暨九十七年度學術研討會,中國醫藥大學,2008.11.15 ~ 2008.11.16,
|
53﹒ |
,第一屆泛太平洋國際幹細胞研討會,中國醫藥大學附設醫院立夫醫療大樓21樓國際會議廳,2008.5.31 ~ 2008.6.2,
|
54﹒ |
,1st Pan Pacific Symposium,Taichung, Taiwan,2008.5.31 ~ 2008.6.2,OEC transplantation treatmetn in spinal cord injury and stroke
|
|
研究計畫/Research Grant (研究類型,研究計畫代號,主持人,補助或委託單位名稱,計畫名稱,研究經費,計畫期間)
|
1﹒ |
個別型,NSTC 112-2314-B-039-073-MY2,張怡雯(CHANG YI-WEN),許家郎(HSU, CHIA-LANG)、江智聖(CHIANG, CHIH-SHENG)、徐偉成(Woei-Cheang Shyu),國科會,探討微膠質前驅細胞在缺血性中風後神經重塑與神經功能恢復所扮演的角色,$1250000,2023.10.1 ~ 2024.9.30
|
2﹒ |
個別型,DMR-113-149,張怡雯(CHANG YI-WEN),鄭隆賓(Long-Bin Jeng)、徐偉成(Woei-Cheang Shyu)、許士超(Shih-Chao Hsu),附醫院內計畫,探索共享新抗原用於開發具有專一性及有效性之新抗原標靶免疫療法以治療肝細胞癌,$300000,2023.8.1 ~ 2024.7.31
|
3﹒ |
整合型(召集人、總主持人),NSTC 112-2823-8-039-003,江智聖(CHIANG, CHIH-SHENG),徐偉成(Woei-Cheang Shyu)、鄭隆賓(Long-Bin Jeng),國科會,開發標靶腫瘤之 INSP精準藥物傳遞技術,$6200000,2023.1.1 ~ 2023.12.31
|
4﹒ |
個別型,MOHW112-TDU-B-212-144004,周德陽(Der-Yang Cho),蔡輔仁(Fuu-Jen Tsai)、陳明豐(Ming-Fong Chen)、李光申(Oscar Kuang-Sheng Lee)、白禮源(Li-Yuan Bai)、徐偉成(Woei-Cheang Shyu)、鄭隆賓(Long-Bin Jeng)、蔡崇豪(Chon-Haw Tsai),衛福部,112年推動臨床試驗發展計畫,$21057000,2023.1.1 ~ 2023.12.31
|
5﹒ |
個別型,DMR-112-170,李瑋(Wei Lee),徐偉成(Woei-Cheang Shyu),附醫院內計畫,IL-22/IL-22R1 途徑能調控心肌細胞球體所衍生之幹細胞在心肌梗塞 上之自我更新和修復潛力,$400000,2022.8.1 ~ 2023.6.30
|
6﹒ |
個別型,MOHW111-TDU-B-212-134004,許重義(Chung Y. Hsu),蔡輔仁(Fuu-Jen Tsai)、陳明豐(Ming-Fong Chen)、周德陽(Der-Yang Cho)、李光申(Oscar Kuang-Sheng Lee)、白禮源(Li-Yuan Bai)、徐偉成(Woei-Cheang Shyu)、鄭隆賓(Long-Bin Jeng)、蔡崇豪(Chon-Haw Tsai),衛福部,111年推動臨床試驗發展計畫,$22539000,2022.1.1 ~ 2022.12.31
|
7﹒ |
個別型,MOST 111-2823-8-039-002,江智聖(CHIANG, CHIH-SHENG),鄭隆賓(Long-Bin Jeng)、徐偉成(Woei-Cheang Shyu),國科會,科研創業計畫:開發標靶三陰性乳癌之新型藥物包覆技術平台,$4800000,2022.1.1 ~ 2022.12.31
|
8﹒ |
個別型,MOST 108-2314-B-039-007-MY3,許斐婷(Hsu, Fei-Ting),徐偉成(Woei-Cheang Shyu)、藍耿立、謝嘉玲、劉華姍,國科會,探討臍帶間葉幹細胞攜帶小分子核糖核酸124或145與免疫T淋巴細胞PD-1受體雙基因表現載體抑制膠質母細胞瘤之效益,$1400000,2021.8.1 ~ 2022.7.31
|
9﹒ |
個別型,MOST 109-2314-B-039-025-MY2,徐偉成(Woei-Cheang Shyu),國科會,探討基因修飾之臍帶幹細胞對於急性心肌梗塞及中風之組織修復,$1265000,2021.8.1 ~ 2022.7.31
|
10﹒ |
個別型,MOST 110-2314-B-039-043-MY3,徐偉成(Woei-Cheang Shyu),林瑄翎(LIN SYUAN-LING),國科會,探討過量表現PD-L1-AKT之脂肪幹細胞所分泌之胞外小體如何影響中風及急性心肌梗塞之治療,$1248000,2021.8.1 ~ 2022.7.31
|
11﹒ |
個別型,DMR-111-141,林瑄翎(LIN SYUAN-LING),徐偉成(Woei-Cheang Shyu),附醫院內計畫,缺氧腫瘤來源的外泌體miR-29a-3p通過PTEN介導M2巨噬細胞極化並促進軟骨肉瘤轉移,$200000,2021.8.1 ~ 2022.7.31
|
12﹒ |
個別型,MOHW110-TDU-B-212-124004,許重義(Chung Y. Hsu),蔡輔仁(Fuu-Jen Tsai)、陳明豐(Ming-Fong Chen)、周德陽(Der-Yang Cho)、李光申(Oscar Kuang-Sheng Lee)、白禮源(Li-Yuan Bai)、徐偉成(Woei-Cheang Shyu)、鄭隆賓(Long-Bin Jeng)、蔡崇豪(Chon-Haw Tsai),衛福部,推動臨床試驗發展計畫,$21139000,2021.1.1 ~ 2021.12.31
|
13﹒ |
個別型,MOST 109-2320-B-039-065-,林瑄翎(LIN SYUAN-LING),徐偉成(Woei-Cheang Shyu)、湯智昕(Chih-Hsin Tang),國科會,研究NGF如何影響軟骨肉瘤轉移的微環境機制以及治療,$900000,2020.10.1 ~ 2021.9.30
|
14﹒ |
個別型,MOST 108-2314-B-039-007-MY3,許斐婷(Hsu, Fei-Ting),徐偉成(Woei-Cheang Shyu)、藍耿立、謝嘉玲、劉華姍,國科會,探討臍帶間葉幹細胞攜帶小分子核糖核酸124或145與免疫T淋巴細胞PD-1受體雙基因表現載體抑制膠質母細胞瘤之效益(2/3),$1400000,2020.8.1 ~ 2021.7.31
|
15﹒ |
個別型,MOST 109-2314-B-039-025-MY2,徐偉成(Woei-Cheang Shyu),國科會,探討基因修飾之臍帶幹細胞對於急性心肌梗塞及中風之組織修復,$1265000,2020.8.1 ~ 2021.7.31
|
16﹒ |
個別型,DMR-110-179,李怡慧(Lee Yi-Hui),徐偉成(Woei-Cheang Shyu),附醫院內計畫,探討體外臍帶血幹細胞增生及分化成紅血球之程序及檢測方式,$500000,2020.8.1 ~ 2021.6.30
|
17﹒ |
個別型,DMR-110-180,林瑄翎(LIN SYUAN-LING),徐偉成(Woei-Cheang Shyu),附醫院內計畫,探討脂肪幹細胞經PDL1-AKT雙基因修飾之新穎胞外小體有助於中風及急性心肌梗塞之治療,$400000,2020.8.1 ~ 2021.6.30
|
18﹒ |
個別型,MOST 109-2321-B-039-002 -,許重義(Chung Y. Hsu),鄭建興、陳志弘、胡朝榮、葉篤學、林秀芬、蔡崇豪(Chon-Haw Tsai)、徐偉成(Woei-Cheang Shyu)、郭育呈(Yuh-Cherng Guo)、李俊泰、林永煬、陳柏霖、林清煌、李宗海、孫穆乾、林欣榮、連立明、吳明修、孫瑜,國科會,台灣中風臨床試驗聯盟 IV,$2000000,2020.5.1 ~ 2021.4.30
|
19﹒ |
個別型,MOHW109-TDU-B-212-114004,許重義(Chung Y. Hsu),林昭庚(Jaung-Geng Lin)、蔡輔仁(Fuu-Jen Tsai)、趙坤山(Kun-San Chao)、陳明豐(Ming-Fong Chen)、周德陽(Der-Yang Cho)、張建國(Jan-Gowth Chang)、白禮源(Li-Yuan Bai)、張恒鴻(Hen-Hong Chang)、藍先元(Hsien-Yuan Lane)、徐偉成(Woei-Cheang Shyu)、鄭隆賓(Long-Bin Jeng)、蔡崇豪(Chon-Haw Tsai),衛福部,109年推動臨床試驗發展計畫,$26711000,2020.1.1 ~ 2020.12.31
|
20﹒ |
個別型,MOST 106-2314-B-039-014-MY3,劉詩平(Liu, Shih-Ping),林欣榮、徐偉成(Shyu, Woei-Cherng)、蔡崇豪(Tsai, Chon-Haw),國科會,利用瀨川氏症基因突變之人類誘導性多能幹細胞進行藥物篩選及細胞治療之研究,$1527000,2019.8.1 ~ 2020.7.31
|
21﹒ |
個別型,MOST 108-2314-B-039-007-MY3,許斐婷(Hsu, Fei-Ting),徐偉成(Woei-Cheang Shyu)、藍耿立、謝嘉玲、劉華姍,國科會,探討臍帶間葉幹細胞攜帶小分子核糖核酸124或145與免疫T淋巴細胞PD-1受體雙基因表現載體抑制膠質母細胞瘤之效益(1/3),$1400000,2019.8.1 ~ 2020.7.31
|
22﹒ |
個別型,MOST 108-2314-B-039-020-,徐偉成(Woei-Cheang Shyu),國科會,利用HA-bioglue之水膠基材建構幹細胞之支架進行神經退化性疾病之治療,$1000000,2019.8.1 ~ 2020.7.31
|
23﹒ |
個別型,DMR-109-033,鄭隆賓(Long-Bin Jeng),鄧喬方(Chiao-Fang Teng)、徐偉成(Woei-Cheang Shyu),附醫院內計畫,結合熱療、樹突狀細胞活化以及免疫檢查點抑制發展多功能奈米藥物用以治療肝癌,$400000,2019.8.1 ~ 2020.7.31
|
24﹒ |
個別型,DMR-109-072,徐偉成(Woei-Cheang Shyu),鄧喬方(Chiao-Fang Teng)、鄭隆賓(Long-Bin Jeng),附醫院內計畫,結合腫瘤細胞裂解物負載之樹突狀細胞和免疫檢查點抑制劑發展有效治療肝癌的疫苗,$300000,2019.8.1 ~ 2020.7.31
|
25﹒ |
個別型,MOHW108-TDU-B-212-133004,許重義(Chung Y. Hsu),林昭庚(Jaung-Geng Lin)、蔡輔仁(Fuu-Jen Tsai)、林正介(Cheng-Chieh Lin)、趙坤山(Kun-San Chao)、陳明豐(Ming-Fong Chen)、周德陽(Der-Yang Cho)、張建國(Jan-Gowth Chang)、卓夙航(Suh-Hang Juo)、張恒鴻(Hen-Hong Chang)、江舟峰、藍先元(Hsien-Yuan Lane)、徐偉成(Woei-Cheang Shyu)、蘇冠賓(Kuan-Pin Su)、陳培君(PEI-CHUN CHEN)、陳怡文(Yi-Wen Chen)、蔡崇豪(Chon-Haw Tsai)、謝慶良(Ching-Liang Hsieh)、李采娟(Tsai-Chung Li)、白禮源(Li-Yuan Bai)、宋鴻樟(Fung-Chung J Sung)、周宜卿(I-Ching Chou)、葉士芃(Shih-Peng Yeh)、謝右文(Yow-Wen Hsieh)、劉崇祥(Chung-Hsiang Liu)、林嘉德(Chia-Der Lin)、洪士杰(Shih-Chieh Hung)、梁基安(Ji-An Liang)、顏宏融(Hung-Rong Yen)、孟乃欣(Nai-Hsin Meng)、黃秋錦(Chiu-Ching Huang)、王怡寬(I-Kuan Wang)、賴世偉(Lai, Shih-Wei)、張坤正(Kuan-Cheng Chang)、劉秋松(Chiu-Shong Liu)、溫啟邦(Chi-Pang Wen)、林志學(Chih-Hsueh Lin)、陳清助(Ching-Chu Chen)、高嘉鴻(Chia-Hung Kao)、蔡文正(Tsai, Wen-Chen)、余養豪、楊良友(Liang-Yo Yang)、温永銳(Yeong-Ray Wen)、楊榮林(Rong-Lin Yang)、呂明桂(Ming-Kuei Lu)、林暉翰(Hui-Han Lin)、薛榮銀、田霓(Ni Tien),衛福部,精進臨床試驗能量及國際躍升計畫,$27584000,2019.1.1 ~ 2019.12.31
|
26﹒ |
個別型,CMU107-N-09,鄧喬方(Chiao-Fang Teng),鄭隆賓(Long-Bin Jeng)、徐偉成(Woei-Cheang Shyu),本校(含附醫),探索B型肝炎病毒Pre-S2突變蛋白異常調控之微型核糖核酸及其在肝癌生成與復發上扮演的角色,$230000,2018.11.7 ~ 2019.7.31
|
27﹒ |
個別型,MOST 106-2314-B-039-014-MY3,劉詩平(Liu, Shih-Ping),林欣榮、徐偉成(Shyu, Woei-Cherng)、蔡崇豪(Tsai, Chon-Haw),國科會,利用瀨川氏症基因突變之人類誘導性多能幹細胞進行藥物篩選及細胞治療之研究,$1527000,2018.8.1 ~ 2019.7.31
|
28﹒ |
個別型,MOST 107-2320-B-039-053-,鄧喬方(Chiao-Fang Teng),鄭隆賓(Long-Bin Jeng)、徐偉成(Woei-Cheang Shyu),國科會,探索新穎的胞外小體之預後生物標記與標靶用以治療肝切除和移植後之肝癌復發,$957000,2018.8.1 ~ 2019.7.31
|
29﹒ |
個別型,DMR-108-065,徐偉成(Woei-Cheang Shyu),鄧喬方(Chiao-Fang Teng),附醫院內計畫,探討第一型人類白血球抗原分子在B型肝炎病毒Pre-S2突變蛋白陽性之肝癌組織中的表現情形,$500000,2018.8.1 ~ 2019.7.31
|
30﹒ |
個別型,MOST 105-2314-B-039-011-MY3,徐偉成(Woei-Cheang Shyu),謝佳宏(Chia-Hung Hsieh)、屈蓮,國科會,探討Bmi-1調控成體嗅黏膜幹細胞之增生及多重分化能力,$1100000,2018.8.1 ~ 2019.7.31
|
31﹒ |
個別型,MOHW107-TDU-B-212-123004,許重義(Hsu, Chung-Y.),林昭庚(Lin, Jaung-Geng)、蔡輔仁(Tsai, Fuu-Jen)、林正介(Lin, Cheng-Chieh)、趙坤山(Chao, Kun-San)、陳明豐(Chen, Ming-Fong)、周德陽(Cho, Der-Yang)、張建國(Chang, Jan-Gowth)、卓夙航(Juo, Suh-Hang)、張恒鴻(Chang, Hen-Hong)、薛榮銀、藍先元(Lane, Hsien-Yuan)、徐偉成(Shyu, Woei-Cherng)、蘇冠賓(Su, Kuan-Pin)、陳怡文(Chen, Yi-Wen)、謝慶良(Hsieh, Ching-Liang)、蔡崇豪(Tsai, Chon-Haw)、白禮源(Bai, Li-Yuan)、李采娟(Li, Tsai-Chung)、周宜卿(Chou, I-Ching)、宋鴻樟(Sung, Fung-Chang)、謝右文(Hsieh, Yow-Wen)、葉士芃(Yeh, Su-Peng)、林嘉德(Lin, Chia-Der)、劉崇祥(Liu, Chung-Hsiang)、梁基安(Liang, Ji-An)、洪士杰(Hung, Shih-Chieh)、孟乃欣(Meng, Nai-Hsin)、顏宏融(Yen, Hung-Rong)、王怡寬(Wang, I-Kuan)、黃秋錦(Huang, Chiu-Ching)、張坤正(Chang, Kuan-Cheng)、賴世偉(Lai, Shih-Wei)、溫啟邦(Wen, Chi-Pang)、劉秋松(Liu, Chiu-Shong)、陳清助(Chen, Ching-Chu)、林志學(Lin, Chih-Hsueh)、蔡文正(Tsai, Wen-Chen)、高嘉鴻(Kao, Chia-Hung)、楊良友(Yang, Liang-Yo)、余養豪(Yu, Yang-Hao)、楊榮林(Yang, Rong-Lin)、温永銳(Wen, Yeong-Ray)、林暉翰(Hui-Han Lin)、呂明桂(Lu, Ming-Kuei)、田霓(Tien, Ni),衛福部,精進臨床試驗能量及國際躍升計畫,$29257000,2018.1.1 ~ 2018.12.31
|
32﹒ |
個別型,MOST 105-2320-B-039-066-MY2,鄧喬方(Teng, Chiao-Fang),鄭隆賓(Jeng, Long-Bin)、徐偉成(Shyu, Woei-Cherng),國科會,結合B型肝炎病毒Pre-S2突變蛋白負載之樹突狀細胞和抑制性腫瘤趨向胞外體發展有效治療肝癌的疫苗,$940000,2017.11.1 ~ 2018.7.31
|
33﹒ |
產學合作,10642645,徐偉成(Shyu, Woei-Cherng),長新生醫國際股份有限公司,精準醫療技術研發,$12000000,2017.11.1 ~ 2018.10.31
|
34﹒ |
個別型,MOST 106-2314-B-039-014-MY3,劉詩平(Liu, Shih-Ping),林欣榮、徐偉成(Shyu, Woei-Cherng)、蔡崇豪(Tsai, Chon-Haw),國科會,利用瀨川氏症基因突變之人類誘導性多能幹細胞進行藥物篩選及細胞治療之研究,$1527000,2017.8.1 ~ 2018.7.31
|
35﹒ |
個別型,DMR-107-148,鄧喬方(Teng, Chiao-Fang),鄭隆賓(Jeng, Long-Bin)、徐偉成(Shyu, Woei-Cherng),附醫院內計畫,B型肝炎病毒Pre-S2突變蛋白誘發之胞外體異常機轉可做為肝癌診斷的生物標記與肝癌治療的分子標靶,$500000,2017.8.1 ~ 2018.6.30
|
36﹒ |
個別型,DMR-107-066,徐偉成(Shyu, Woei-Cherng),鄧喬方(Teng, Chiao-Fang),附醫院內計畫,以B型肝炎病毒Pre-S2突變蛋白表現之肝癌細胞裂解物負載之樹突狀細胞合併免疫檢查點PD-1抗體發展有效治療肝癌的疫苗,$400000,2017.8.1 ~ 2018.7.31
|
37﹒ |
學生參與計畫,CMU106-SR-112,徐偉成(Shyu, Woei-Cherng),本校(含附醫),台灣杉木脂素Taiwanin A抑制人類三陰性乳癌細胞生長機制,$35000,2017.8.1 ~ 2018.2.28
|
38﹒ |
個別型,MOST 105-2314-B-039-011-MY3,徐偉成(Shyu, Woei-Cherng),謝佳宏(Hsieh, Chia-Hung)、屈蓮(Lian Chiu),國科會,探討Bmi-1調控成體嗅黏膜幹細胞之增生及多重分化能力,$1056000,2017.8.1 ~ 2018.7.31
|
39﹒ |
學生參與計畫,106-2813-C-039-112-B,徐偉成(Shyu, Woei-Cherng),國科會,台灣杉木脂素Taiwanin A抑制人類三陰性乳癌細胞生長機制,$48000,2017.7.1 ~ 2018.2.28
|
40﹒ |
整合型項下子計畫(主持人),BM10601010036,許重義(Chung Y. Hsu),陳朝榮(Chao-Jung Chen)、沈明毅(Ming-Yi Shen)、胡朝榮、湯頌君、吳明修、徐偉成(Woei-Cherng Shyu),中研院,臺灣人體生物資料庫腦中風之生物標誌研發,$4500000,2017.1.1 ~ 2017.12.31
|
41﹒ |
個別型,MOHW106-TDU-B-212-113004,許重義(Chung Y. Hsu),林昭庚(Jaung-Geng Lin)、蔡輔仁(Fuu-Jen Tsai)、林正介(Cheng-Chieh Lin)、趙坤山(Kun-San Chao)、陳明豐(Chen Ming-Fong)、周德陽(Der-Yang Cho)、張建國(Jan-Gowth Chang)、姚俊旭(Chun-Hsu Yao)、張恒鴻(CHANG,HEN-HONG)、薛榮銀、藍先元(Hsien-Yuan Lane)、徐偉成(Woei-Cherng Shyu)、程瀚毅、蘇冠賓(Kuan-Pin Su),衛福部,精進臨床試驗能量及國際躍升計畫,$29482000,2017.1.1 ~ 2017.12.31
|
42﹒ |
個別型,MOST 105-2320-B-039-066-MY2,鄧喬方(Chiao-Fang Teng),鄭隆賓(Jeng, Long-Bin)、徐偉成(Shyu, Woei-Cherng),國科會,結合B型肝炎病毒Pre-S2突變蛋白負載之樹突狀細胞和抑制性腫瘤趨向胞外體發展有效治療肝癌的疫苗,$1250000,2016.11.1 ~ 2017.10.31
|
43﹒ |
個別型,MOST 105-2314-B-039-011-MY3,徐偉成(Woei-Cherng Shyu),謝佳宏(Chia-Hung Hsieh)、屈蓮(Lian Chiu),國科會,探討Bmi-1調控成體嗅黏膜幹細胞之增生及多重分化能力(1/3),$1100000,2016.8.1 ~ 2017.7.31
|
44﹒ |
國家型,MOST 105-2325-B-039-003-,許重義(Chung Y. Hsu),鄭建興、陳志弘、胡朝榮、林昭庚(Jaung-Geng Lin)、周德陽(Der-Yang Cho)、林欣榮(Shinn-Zong Lin)、徐偉成(Woei-Cherng Shyu)、蔡崇豪(Chon-Haw Tsai)、陳春忠(CHUN-CHUNG CHEN)、謝慶良(Ching-Liang Hsieh)、李俊泰、林清煌、孫穆乾、連立明、孫瑜,,台灣中風臨床試驗聯盟 III,$3999000,2016.5.1 ~ 2017.4.30
|
45﹒ |
國家型,MOHW105-NRICM-C-104-122-001,謝慶良(Ching-Liang Hsieh),蔡崇豪(Chon-Haw Tsai)、黃偉師(Wei-Shih Huang)、劉崇祥(Chung-Hsiang Liu)、呂明桂(Ming-Kuei Lu)、徐偉成(Woei-Cherng Shyu)、楊玉婉(Yu-Wan Yang)、曾鈞宏(Chun-Hung Tseng)、黃匯淳(Hui-Chun Huang)、許怡婷(Yi-Ting Hsu(Hseu))、周立偉(Li-Wei Chou)、郭育呈(Yuh-Cherng Guo)、林昭庚(Jaung-Geng Lin)、李采娟(Tsai-Chung Li)、顏宏融(Hung-Rong Yen)、陳睿正(Jui-Cheng Chen)、陳冠妃(Kuan-Fei Chen)、賴仲亮(Chung-Liang Lai),衛福部,「中藥品質及中醫藥輔助療效研究」計畫-後續擴充105年,$1317000,2016.4.1 ~ 2017.3.31
|
46﹒ |
整合型項下子計畫(主持人),BM10501010037,許重義(Chung Y. Hsu),陳朝榮(Chao-Jung Chen)、沈明毅(Ming-Yi Shen)、胡朝榮、湯頌君、吳明修、徐偉成(Woei-Cherng Shyu),中研院,臺灣人體生物資料庫腦中風之生物標誌研發,$5000000,2016.1.1 ~ 2016.12.31
|
47﹒ |
個別型,MOHW105-TDU-B-212-133019,許重義(Chung Y. Hsu),周德陽(Der-Yang Cho)、林欣榮(Shinn-Zong Lin)、姚俊旭(Chun-Hsu Yao)、蔡輔仁(Fuu-Jen Tsai)、邱俊誠(Jin-Chern Chiou)、林昭庚(Jaung-Geng Lin)、謝慶良(Ching-Liang Hsieh)、林正介(Cheng-Chieh Lin)、郭昭麟(Kuo Chao-Lin)、李信達(Shin-Da Lee)、徐偉成(Woei-Cherng Shyu)、張建國(Jan-Gowth Chang),衛福部,提升臨床試驗創新及競爭力計畫,$33781000,2016.1.1 ~ 2016.12.31
|
48﹒ |
個別型,NSC 102-2628-B-039-008-MY3,張顥騰(Hao-Teng Chang),徐偉成(Woei-Cherng Shyu),國科會,G72蛋白質過度表現於肌萎縮性側索硬化症小鼠之研究,$1301000,2015.8.1 ~ 2016.7.31
|
49﹒ |
個別型,DMR-105-056,徐偉成(Woei-Cherng Shyu),附醫院內計畫,探討CXCR7在膠原蛋白誘發關節炎模式中利用幹細胞治療之多重角色,$400000,2015.8.1 ~ 2016.7.31
|
50﹒ |
個別型,CMU104-S-15-03,徐偉成(Woei-Cheang Shyu),本校(含附醫),調控NR2A and NR2B以治療神經退化疾病-以NMDA受體調節劑治療急性神經損傷-缺血性腦中風,$335000,2015.8.1 ~ 2016.7.31
|
51﹒ |
個別型,CMU104-S-10,徐偉成(Woei-Cheang Shyu),本校(含附醫),發展透明質酸生物膠複合藥物用於抗腦神經膠質瘤,$350000,2015.8.1 ~ 2016.7.31
|
52﹒ |
國家型,MOST 104-2325-B-039-005 -,許重義(Chung Y. Hsu),鄭建興、陳志弘、卓夙航、徐偉成(Woei-Cherng Shyu)、劉崇祥(Chung-Hsiang Liu)、李俊泰、陳昌明、林清煌、孫穆乾、連立明,國科會,台灣中風疾病臨床試驗合作聯盟Ⅱ,$4000000,2015.5.1 ~ 2016.4.30
|
53﹒ |
國家型,MOHW104-NRICM-C-104-112-001,謝慶良(Ching-Liang Hsieh),蔡崇豪(Chon-Haw Tsai)、黃偉師(Wei-Shih Huang)、劉崇祥(Chung-Hsiang Liu)、呂明桂(Ming-Kuei Lu)、徐偉成(Woei-Cherng Shyu)、楊玉婉(Yu-Wan Yang)、曾鈞宏(Chun-Hung Tseng)、黃匯淳(Hui-Chun Huang)、許怡婷(Yi-Ting Hsu(Hseu))、周立偉(Li-Wei Chou)、郭育呈(Yuh-Cherng Guo)、林昭庚(Jaung-Geng Lin)、李采娟(Tsai-Chung Li)、顏宏融(Hung-Rong Yen)、陳睿正(Jui-Cheng Chen)、陳冠妃(Kuan-Fei Chen),衛福部,104年度「中藥品質及中醫藥輔助療效研究」計畫,$1500000,2015.4.1 ~ 2016.3.31
|
54﹒ |
個別型,MOHW104-TDU-B-212-113002,許重義(Chung Y. Hsu),周德陽(Der-Yang Cho)、林欣榮(Shinn-Zong Lin)、吳金濱(Jin Bin Wu)、蔡輔仁(Fuu-Jen Tsai)、邱俊誠(Jin-Chern Chiou)、謝慶良(Ching-Liang Hsieh)、林正介(Cheng-Chieh Lin)、郭昭麟(Kuo Chao-Lin)、李信達(Shin-Da Lee)、徐偉成(Woei-Cherng Shyu),衛福部,提升臨床試驗創新及競爭力計畫,$31300000,2015.1.1 ~ 2015.12.31
|
55﹒ |
國家型,MOST 103-2325-B-039-010,謝佳宏,徐偉成,,探討胱氨酸-谷氨酸逆向轉運子在大腦中風中谷氨酸誘導神經毒性之角色與治療(1/2),$2200000,2014.11.1 ~ 2015.10.31
|
56﹒ |
個別型,CMU103-BC-6,徐偉成(Woei-Cheang Shyu),本校(含附醫),嗜伊紅性白血球陽離子蛋白質在先天性免疫力對腫瘤化之角色與治療應用,子計畫1:探討嗜伊紅性白血球陽離子蛋白質在乳癌過程之角色,$1000000,2014.10.14 ~ 2015.7.31
|
57﹒ |
個別型,NSC 102-2628-B-039-008-MY3,張顥騰(Hao-Teng Chang),徐偉成(Woei-Cherng Shyu),國科會,G72蛋白質過度表現於肌萎縮性側索硬化症小鼠之研究,$1301000,2014.8.1 ~ 2015.7.31
|
58﹒ |
個別型,MOST 103-2325-B-039-001,徐偉成(Woei-Cherng Shyu),周德陽(Der-Yang Cho)、林欣榮(Shinn-Zong Lin)、許重義(Chung Y. Hsu)、李旭東(Syu-Dong Lee),國科會,以自體嗅鞘幹細胞(Olfactory ensheathing cells—OECs)腦部移植治療陳舊性缺血性腦中風病人之第一期臨床試驗研究(3/3),$2120000,2014.8.1 ~ 2015.7.31
|
59﹒ |
個別型,DMR-104-054,徐偉成(Woei-Cherng Shyu),謝佳宏(Chia-Hung Hsieh),附醫院內計畫,探討SDF-1/CXCR7訊息在下肢缺血組織中調節血管新生之角色與機轉,$200000,2014.8.1 ~ 2015.7.31
|
60﹒ |
國家型,MOST 103-2325-B-039-006-,許重義(Chung Y. Hsu),鄭建興、陳志弘、徐偉成(Woei-Cherng Shyu)、劉崇祥(Chung-Hsiang Liu)、李俊泰、陳昌明、孫穆乾、連立明,國科會,台灣中風疾病臨床試驗合作聯盟 I,$4000000,2014.5.1 ~ 2015.4.30
|
61﹒ |
國家型,NRICM103-CR-01,謝慶良(Ching-Liang Hsieh),蔡崇豪(Chon-Haw Tsai)、黃偉師(Wei-Shih Huang)、劉崇祥(Chung-Hsiang Liu)、呂明桂(Ming-Kuei Lu)、徐偉成(Woei-Cherng Shyu)、楊玉婉(Yu-Wan Yang)、曾鈞宏(Chun-Hung Tseng)、黃匯淳(Hui-Chun Huang)、許怡婷(Yi-Ting Hsu(Hseu))、周立偉(Li-Wei Chou)、郭育呈(Yuh-Cherng Guo)、林昭庚(Jaung-Geng Lin)、李采娟(Tsai-Chung Li)、顏宏融(Hung-Rong Yen),衛福部,103年度中醫藥轉譯計畫「中藥複方輔助治療缺血型中風臨床療效評估委託研究計畫」,$1518000,2014.4.24 ~ 2015.3.31
|
62﹒ |
個別型,MOHW103-TDU-B-212-113002,許重義(Chung Y. Hsu),周德陽(Der-Yang Cho)、林欣榮(Shinn-Zong Lin)、吳金濱(Jin Bin Wu)、蔡輔仁(Fuu-Jen Tsai)、邱俊誠(Jin-Chern Chiou)、謝慶良(Ching-Liang Hsieh)、林正介(Cheng-Chieh Lin)、郭昭麟(Kuo Chao-Lin)、李信達(Shin-Da Lee)、徐偉成(Woei-Cherng Shyu),衛福部,103-105年提升臨床試驗創新及競爭力計畫,$33000000,2014.2.27 ~ 2014.12.31
|
63﹒ |
非研究型計畫 (例如:課程計畫),NSC 102-2811-B-039-032,林欣榮(Shinn-Zong Lin),許重義(Chung Y. Hsu)、徐偉成(Woei-Cherng Shyu),國科會,幹細胞之訊息途徑及表基因調控─探討FOXC1藉由SDF-1?/CXCR4之表現來調控arachnoid stem cells之增生--總計畫暨子計畫五(3/3)」,$906856,2013.10.1 ~ 2014.9.30
|
64﹒ |
整合型(召集人、總主持人),NSC 102-2321-B-039-006,林欣榮(Shinn-Zong Lin),許重義(Chung Y. Hsu)、徐偉成(Woei-Cherng Shyu),國科會,幹細胞之訊息途徑及表基因調控-探討FOXC1藉由SDF-1α/CXCR4之表現來調控arachnoid stem cells之增生--總計畫暨子計畫五(3/3),$6600000,2013.10.1 ~ 2014.9.30
|
65﹒ |
個別型,NSC 100-2314-B-039-016-MY,李信達(Shin-Da Lee),郭家驊、黃志揚(Chih-Yang Huang)、徐偉成(Woei-Cherng Shyu),國科會,運動治療與Exchange protein activated by cAMP (Epac1)對糖尿病心臟與腦部的幹細胞自誘導機轉與抗凋亡機轉,$614000,2013.8.1 ~ 2014.7.31
|
66﹒ |
非研究型計畫 (例如:課程計畫),NSC 102-2811-B-039-019,徐偉成(Woei-Cherng Shyu),國科會,探討經由缺氧誘導因子-1(HIF-1?)活化Epac1-Rap1訊息表現進而增強顆粒球生長激素(G-CSF)誘發之神經再生研究,$827994,2013.8.1 ~ 2014.7.31
|
67﹒ |
個別型,NSC 102-2325-B-039-006,徐偉成(Woei-Cherng Shyu),周德陽(Der-Yang Cho)、林欣榮(Shinn-Zong Lin)、李旭東,國科會,以自體嗅鞘幹細胞(Olfactory ensheathing cells—OECs)腦部移植治療陳舊性缺血性腦中風病人之第一期臨床試驗研究(2/3),$2728000,2013.8.1 ~ 2014.7.31
|
68﹒ |
個別型,NSC 100-2314-B-039-002-MY3,徐偉成(Woei-Cherng Shyu),國科會,探討經由缺氧誘導因子-1(HIF-1α)活化Epac1-Rap1訊息表現進而增強顆粒球生長激素(G-CSF)誘發之神經再生研究,$1050000,2013.8.1 ~ 2014.7.31
|
69﹒ |
整合型(召集人、總主持人),NSC 100-2632-B-039 -001 -MY3,許重義(Chung Y. Hsu),王玉田(Yu-Tian Wang)、林欣榮(Shinn-Zong Lin)、徐偉成(Woei-Cherng Shyu)、李信達(Shin-Da Lee),國科會,多重谷氨酸次型受體導致腦中風後神經元死亡之機制-多重谷氨酸次型受體導致腦中風後神經元死亡之機制(3/3),$3300000,2013.8.1 ~ 2014.7.31
|
70﹒ |
個別型,NSC 102-2628-B-039-008-MY3,張顥騰(Hao-Teng Chang),徐偉成(Woei-Cherng Shyu),國科會,G72蛋白質過度表現於肌萎縮性側索硬化症小鼠之研究,$1301000,2013.8.1 ~ 2014.7.31
|
71﹒ |
產學合作,101426BQ,張顥騰(Hao-Teng Chang),徐偉成(Woei-Cherng Shyu)、蔡崇豪(Chon-Haw Tsai),億康生物科技公司,以HMGB1為肌萎縮性脊髓側索硬化症檢測之生物指標,$346380,2013.6.1 ~ 2014.5.31
|
72﹒ |
國家型,NSC 102-2325-B-039 -001 -,許重義(Chung Y. Hsu),吳天賞、陳語謙(Calvin Yu-Chian Chen)、郭悅雄(Yueh-Hsiung Kuo)、林欣榮(Shinn-Zong Lin)、王玉田(Yu-Tian Wang)、徐偉成(Woei-Cherng Shyu)、郭盛助(Sheng-Chu Kuo)、吳永昌(Yang-Chang Wu)、韓鴻志(Horng-Jyh Harn)、林瓊,國科會,由多重谷氨酸次型受體機制開創治療腦中風新藥(3/3),$5212000,2013.5.1 ~ 2014.4.30
|
73﹒ |
產學合作,101426AQ,徐偉成(Woei-Cherng Shyu),成漢生物科技股份有限公司,乳牙幹細胞治療性麻痺動物試驗,$300000,2013.4.1 ~ 2013.12.31
|
74﹒ |
國家型,DOH102-TD-B-111-004,許重義(Chung Y. Hsu),李源德(Yuan-Teh, Lee)、陳偉德(Walter Chen)、周德陽(Der-Yang Cho)、林欣榮(Shinn-Zong Lin)、蔡輔仁(Fuu-Jen Tsai)、邱俊誠(Jin-Chern Chiou)、謝慶良(Ching-Liang Hsieh)、吳天賞(Tian-Shung Wu)、吳永昌(Yang-Chang Wu)、林正介(Cheng-Chieh Lin)、郭昭麟(Kuo Chao-Lin)、李信達(Shin-Da Lee)、徐偉成(Woei-Cherng Shyu)、鄭光甫(Kuang-Fu Cheng),衛福部,中風及其他神經疾病專科卓越臨床試驗與研究中心計畫,$32974000,2013.1.1 ~ 2013.12.31
|
75﹒ |
非研究型計畫 (例如:課程計畫),NSC 101-2811-B-039-028,徐偉成(Woei-Cherng Shyu),國科會,探討經由缺氧誘導因子-1(HIF-1?)活化Epac1-Rap1訊息表現進而增強顆粒球生長激素(G-CSF)誘發之神經再生研究,$608604,2012.11.1 ~ 2013.7.31
|
76﹒ |
整合型(召集人、總主持人),NSC 101-2321-B-039-006,林欣榮(Shinn-Zong Lin),許重義(Chung Y. Hsu)、徐偉成(Woei-Cherng Shyu),國科會,幹細胞之訊息途徑及表基因調控-探討FOXC1藉由SDF-1α/CXCR4之表現來調控arachnoid stem cells之增生--總計畫暨子計畫五(2/3),$6600000,2012.10.1 ~ 2013.9.30
|
77﹒ |
個別型,NSC 99-2314-B-039-004-MY3,鄭宇容(Cheng, Yu-Jung),徐偉成(Woei-Cherng Shyu),國科會,運動對腦中風後細胞外基質的改變,$735000,2012.8.1 ~ 2013.7.31
|
78﹒ |
整合型項下子計畫(主持人),NSC 100-2632-B-039 -001 -MY3,許重義(Chung Y. Hsu),王玉田(Yu-Tian Wang)、林欣榮(Shinn-Zong Lin)、徐偉成(Woei-Cherng Shyu)、李信達(Shin-Da Lee),國科會,多重谷氨酸次型受體導致腦中風後神經元死亡之機制-多重谷氨酸次型受體導致腦中風後神經元死亡之機制(2/3),$3300000,2012.8.1 ~ 2013.7.31
|
79﹒ |
個別型,NSC 100-2314-B-039-002-MY,徐偉成(Woei-Cherng Shyu),國科會,探討經由缺氧誘導因子-1(HIF-1α)活化Epac1-Rap1訊息表現進而增強顆粒球生長激素(G-CSF)誘發之神經再生研究,$1050000,2012.8.1 ~ 2013.7.31
|
80﹒ |
個別型,NSC 101-2325-B-039 -001 -,許重義(Chung Y. Hsu),吳天賞(Tian-Shung Wu)、陳語謙(Calvin Yu-Chian Chen)、郭悅雄(Yueh-Hsiung Kuo)、林欣榮(Shinn-Zong Lin)、王玉田(Yu-Tian Wang)、徐偉成(Woei-Cherng Shyu)、郭盛助(Sheng-Chu Kuo)、吳永昌(Yang-Chang Wu)、韓鴻志(Horng-Jyh Harn)、林瓊(Chiung Lin),國科會,由多重谷氨酸次型受體機制開創治療腦中風新藥(2/3),$5148000,2012.5.1 ~ 2013.4.30
|
81﹒ |
個別型,NSC 101-2325-B-039-006,徐偉成(Woei-Cherng Shyu),周德陽(Der-Yang Cho)、許重義(Chung Y. Hsu)、林欣榮(Shinn-Zong Lin)、李旭東,國科會,以自體嗅鞘幹細胞(Olfactory ensheathing cells—OECs)腦部移植治療陳舊性缺血性腦中風病人之第一期臨床試驗研究(1/3),$3000000,2012.2.1 ~ 2013.7.31
|
82﹒ |
國家型,DOH101-TD-B-111-004,許重義(Chung Y. Hsu),李源德(Yuan-Teh, Lee)、陳偉德(Walter Chen)、周德陽(Der-Yang Cho)、林欣榮(Shinn-Zong Lin)、蔡輔仁(Fuu-Jen Tsai)、邱俊誠(Jin-Chern Chiou)、謝慶良(Ching-Liang Hsieh)、吳天賞(Tian-Shung Wu)、吳永昌(Yang-Chang Wu)、林正介(Cheng-Chieh Lin)、郭昭麟(Kuo Chao-Lin)、李信達(Shin-Da Lee)、徐偉成(Woei-Cherng Shyu)、鄭光甫(Kuang-Fu Cheng),衛福部,中風及其他神經疾病專科卓越臨床試驗與研究中心計畫,$35445000,2012.1.1 ~ 2012.12.31
|
83﹒ |
產學合作,100426AL,徐偉成(Woei-Cherng Shyu),,細胞分離器材效能測試與動物試驗分析,$810000,2012.1.1 ~ 2012.12.20
|
84﹒ |
整合型(召集人、總主持人),NSC 100-2321-B-039-005,林欣榮(Shinn-Zong Lin),許重義(Chung Y. Hsu)、徐偉成(Woei-Cherng Shyu),國科會,幹細胞之訊息途徑及表基因調控-探討FOXC1藉由SDF-1α/CXCR4之表現來調控arachnoid stem cells之增生--總計畫暨子計畫五(1/3),$6600000,2011.10.1 ~ 2012.9.30
|
85﹒ |
非研究型計畫 (例如:課程計畫),NSC 100-2811-B-039-020,徐偉成(Woei-Cherng Shyu),國科會,探討經由缺氧誘導因子-1(HIF-1)活化Epac1-Rap1訊息表現進而增強顆粒球生長激素(G-CSF)誘發之神經再生研究,$663982,2011.10.17 ~ 2012.7.31
|
86﹒ |
個別型,NSC 99-2314-B-039-004-MY3,鄭宇容(Cheng, Yu-Jung),徐偉成(Woei-Cherng Shyu),國科會,運動對腦中風後細胞外基質的改變,$735000,2011.8.1 ~ 2012.7.31
|
87﹒ |
整合型(召集人、總主持人),NSC 100-2632-B-039-001-MY,許重義(Chung Y. Hsu),王玉田(Yu-Tian Wang)、林欣榮(Shinn-Zong Lin)、徐偉成(Woei-Cherng Shyu)、李信達(Shin-Da Lee),國科會,多重谷氨酸次型受體導致腦中風後神經元死亡之機制-多重谷氨酸次型受體導致腦中風後神經元死亡之機制,$3300000,2011.8.1 ~ 2012.7.31
|
88﹒ |
個別型,NSC 100-2314-B-039-002-MY,徐偉成(Woei-Cherng Shyu),國科會,探討經由缺氧誘導因子-1(HIF-1α)活化Epac1-Rap1訊息表現進而增強顆粒球生長激素(G-CSF)誘發之神經再生研究,$1050000,2011.8.1 ~ 2012.7.31
|
89﹒ |
國家型,NSC 100-2325-B-039-001,許重義(Chung Y. Hsu),吳天賞(Tian-Shung Wu)、陳語謙(Calvin Yu-Chian Chen)、郭悅雄、林欣榮(Shinn-Zong Lin)、王玉田(Yu-Tian Wang)、徐偉成(Woei-Cherng Shyu)、郭盛助(Sheng-Chu Kuo)、吳永昌、韓鴻志(Horng-Jyh Harn)、林瓊,國科會,由多重谷氨酸次型受體機制開創治療腦中風新藥(1/3),$5000000,2011.5.1 ~ 2012.4.30
|
90﹒ |
國家型,DOH100-TD-B-111-004,許重義(Chung Y. Hsu),李源德(Yuan-Teh, Lee)、陳偉德(Walter Chen)、周德陽(Der-Yang Cho)、林欣榮(Shinn-Zong Lin)、蔡輔仁(Fuu-Jen Tsai)、邱俊誠(Jin-Chern Chiou)、謝慶良(Ching-Liang Hsieh)、吳天賞(Tian-Shung Wu)、吳永昌、林正介(Cheng-Chieh Lin)、郭昭麟(Kuo Chao-Lin)、李信達(Shin-Da Lee)、徐偉成(Woei-Cherng Shyu)、鄭光甫(Kuang-Fu Cheng),衛福部,中風及其他神經疾病專科卓越臨床試驗與研究中心計畫,$40500000,2011.1.1 ~ 2011.12.31
|
91﹒ |
產學合作,098426Y5,徐偉成(Woei-Cherng Shyu),工研院,細胞標定與體內追蹤之奈米顯影劑開發-IOP分離之CD34+血液幹細胞移植中風動物模式之組織再生與顯影效能分析,$900000,2011.1.1 ~ 2011.12.20
|
92﹒ |
產學合作,0994264G,徐偉成(Woei-Cherng Shyu),臺美生技股份有限公司,以自體嗅虓鞘幹細胞腦部移植治療陳舊性缺血性腦中風病人之第一期臨床試驗研究,$1000000,2010.10.1 ~ 2011.9.30
|
93﹒ |
個別型,NSC 97-2628-B-039-001-MY3,徐偉成(Woei-Cherng Shyu),林欣榮(Shinn-Zong Lin),國科會,探討具有表現胰島素生長因子受體(IGF1R)之臍帶間質幹細胞擁有多潛力分化能力並能促進腦內之神經再生於腦中風及巴金森鼠中,$900000,2010.8.1 ~ 2011.7.31
|
94﹒ |
個別型,NSC 97-2314-B-039-036-MY3,徐偉成(Woei-Cherng Shyu),林欣榮(Shinn-Zong Lin),國科會,探討PRION蛋白及其LIGAND壓力誘發蛋白(STI-1)之交互作用與幹細胞移行及促進血管增生之相關性研究,$800000,2010.8.1 ~ 2011.7.31
|
95﹒ |
個別型,NSC 97-2314-B-039-011-MY3,林欣榮(Shinn-Zong Lin),徐偉成(Woei-Cherng Shyu),國科會,探討腦內移植周邊血幹細胞來調控巴金森鼠之神經功能朔性及其分子機轉,$3360000,2010.8.1 ~ 2011.7.31
|
96﹒ |
個別型,NSC 99-2314-B-039-004-MY3,鄭宇容(Cheng, Yu-Jung),徐偉成(Woei-Cherng Shyu),國科會,運動對腦中風後細胞外基質的改變,$735000,2010.8.1 ~ 2011.7.31
|
97﹒ |
個別型,DMR-99-175,陳睿正(Jui-Cheng Chen),蔡崇豪(Chon-Haw Tsai)、徐偉成(Woei-Cherng Shyu),附醫院內計畫,陳舊性腦梗塞病人經由腦內自體週邊血幹細胞移植後其動作皮質準備電位,腦間抑制,及動作誘發電位之變化,$150000,2010.2.1 ~ 2010.12.31
|
98﹒ |
整合型項下子計畫(主持人),NSC 100-2321-B-039 -001,陳偉德(Walter Chen),陳階曉(CHIEH-HSIAO CHEN)、林必盛(Bih-Chern Lin)、蔡銘修(Ming-Hsui Tsai)、吳介信(Chieh-Hsi Wu)、徐偉成(Woei-Cherng Shyu)、李信達(Shin-Da Lee)、周立偉(Li-Wei Chou)、蔡昆熹(Kun-Hsi Tsai)、韓鴻志(Horng-Jyh Harn)、沈淵瑤(Ein-Yiao Shen),國科會,醫療器材跨領域萌芽創新計畫,$5000000,2010.2.1 ~ 2011.1.31
|
99﹒ |
產學合作,0994263E,徐偉成(Woei-Cherng Shyu),林欣榮(Shinn-Zong Lin),,以自體幹細胞腦部移植治療陳舊性缺血性腦中風病人之第二期臨床試驗研究,$15390332,2010.1.1 ~ 2013.12.31
|
100﹒ |
整合型項下子計畫(主持人),CMU98-CT-24,徐偉成(Woei-Cherng Shyu),本校(含附醫),Upregulation of SDF-1/CXCR4 enhances neuro-plasticity through MSCs and (EPCs-hUCB34) co-transplantation in stroke animal models,$312628,2009.12.1 ~ 2010.11.30
|
101﹒ |
非研究型計畫 (例如:課程計畫),98-教-方案7-B-75,林欣榮(Shinn-Zong Lin),徐偉成(Woei-Cherng Shyu),教育部,探討腦內移植周邊血幹細胞來調控巴金森鼠之神經功能朔性及其分子機轉,$408712,2009.11.1 ~ 2010.10.31
|
102﹒ |
個別型,NSC97-2321-B-039-001-MY2,劉德模(Demeral David Liu),徐偉成(Woei-Cherng Shyu),國科會,從鼻息肉手術檢體分離、培養人類嗅覺鞘細胞及神經幹細胞、暨其對缺氧壓力下神經順商模式之神經再生研究,$1130000,2009.8.1 ~ 2010.7.31
|
103﹒ |
個別型,DMR-99-064,林昭君(Chao-Chun Lin),劉益瑞(Yi-Jui Liu)、沈戊忠(Wu-Chung Shen)、徐偉成(Woei-Cherng Shyu),附醫院內計畫,用T2*衰減值定量分析超順磁氧化奈米磁珠標記的細胞數: 從假體到動物試驗,$300000,2009.8.1 ~ 2010.7.31
|
104﹒ |
個別型,DMR-99-078,陳德誠(Der-Cherng Chen),謝慶良(Ching-Liang Hsieh)、徐偉成(Woei-Cherng Shyu)、周德陽(Der-Yang Cho),附醫院內計畫,探討Ferulic Acid治療慢性腦中風老鼠中抗發炎及抗氧化機制之研究,$150000,2009.8.1 ~ 2010.7.31
|
105﹒ |
個別型,DMR-99-051,邱曉郁(Hsiao-Yu Chiu),蘇百弘(Bai-Horng Su)、巫康熙(Kang-Hsi Wu)、徐偉成(Woei-Cherng Shyu),附醫院內計畫,移植人類幹細胞治療新生小鼠缺氧缺血腦病變,$300000,2009.8.1 ~ 2010.7.31
|
106﹒ |
產學合作,097426K3,徐偉成(Woei-Cherng Shyu),Neuralstem,INTRACEREBRAL IMPLANTATION OF ADHERENT HUMAN NEURAL STEM CELLS(OR NEURAL PROGENITOR CELLS OR,$1500000,2009.6.1 ~ 2011.12.31
|
107﹒ |
個別型,NSC 97-2628-B-039-001-MY3,徐偉成(Woei-Cherng Shyu),林欣榮(Shinn-Zong Lin),國科會,探討具有表現胰島素生長因子受體(IGF1R)之臍帶間質幹細胞擁有多潛力分化能力並能促進腦內之神經再生於腦中風及巴金森鼠中,$1000000,2008.8.1 ~ 2009.7.31
|
108﹒ |
個別型,NSC 97-2314-B-039-036-MY3,徐偉成(Woei-Cherng Shyu),林欣榮(Shinn-Zong Lin),國科會,探討PRION蛋白及其LIGAND壓力誘發蛋白(STI-1)之交互作用與幹細胞移行及促進血管增生之相關性研究,$900000,2008.8.1 ~ 2009.7.31
|
109﹒ |
個別型,NSC 97-2314-B-039-011-MY3,林欣榮(Shinn-Zong Lin),徐偉成(Woei-Cherng Shyu),國科會,探討腦內移植周邊血幹細胞來調控巴金森鼠之神經功能朔性及其分子機轉,$1120000,2008.8.1 ~ 2009.7.31
|
110﹒ |
個別型,NSC97-2314-B-039-011-MY3,林欣榮(Shinn-Zong Lin),徐偉成(Woei-Cherng Shyu),國科會,探討腦內移植周邊血幹細胞來調控巴金森鼠之神經功能朔性及其分子機轉,$1120000,2008.8.1 ~ 2009.7.31
|
111﹒ |
個別型,NSC 96-2314-B-039-027,林欣榮(Shinn-Zong Lin),徐偉成(Woei-Cherng Shyu),國科會,探討以人類胎盤間質幹細胞治療神經退化性疾病動物模式之可行性研究(3/3),$1018000,2007.8.1 ~ 2008.7.31
|
|
專利/Patent (專利名稱,專利類別,專利國別,專利號碼,專利期間)
|
1﹒ |
新穎誘導性多能幹細胞(IPSCS)及其應用,發明專利,台灣,I769410,2022.7.1 ~ 2039.10.27
|
2﹒ |
Immunomagnetic nanocapsule and kit for treating cancer,發明專利,美國,US 10,736,964 B2,2020.8.11 ~ 2038.12.7
|
3﹒ |
免疫磁性組成物、其製備方法、其用途以及治療癌症之套組,發明專利,台灣,I664983,2019.7.11 ~ 2038.1.15
|
4﹒ |
20(S)-sulfonylamidine derivatives of camptothecin and the use thereof as a potent antitumor agent,發明專利,韓國,KR 101844802,2018.3.28 ~ 2038.3.28
|
5﹒ |
20(S)-sulfonylamidine derivatives of camptothecin and the use thereof as a potent antitumor agent,發明專利,美國,US9718835,2017.8.1 ~ 2037.8.1
|
6﹒ |
間質幹細胞、其純株化擴張之方法、其分離方法及其應用,發明專利,台灣,I589698,2017.7.1 ~ 2035.7.21
|
7﹒ |
喜樹鹼的新穎20(S)-磺基脒衍生物及其抗腫瘤劑的用途,發明專利,台灣,TWI526446,2016.3.21 ~ 2034.9.18
|
8﹒ |
Magnetic separation unit, magnetic separation device and method for separating magnetic substance in bio-samples,發明專利,台灣,US 8,993,342 B2,2015.3.31 ~ 2035.3.30
|
9﹒ |
Magnetic separation device and method for separating magnetic substance in bio-samples,發明專利,美國,US 8,701,893 B2,2014.4.22 ~ 2034.4.21
|
10﹒ |
磁性分離單元、磁性分離裝置以及分離生化試樣內磁性物質之方法,發明專利,台灣,I407101號,2013.9.1 ~ 2031.4.10
|
11﹒ |
Pluripotent Olfactory Stem Cells,發明專利,美國,8329166,2012.12.11 ~ 2032.12.11
|
12﹒ |
磁性分離裝置以及分離生化試樣內磁性物質方法,發明專利,台灣,I362964,2012.5.1 ~ 2029.12.22
|
13﹒ |
一種用於治療腦組織損傷之套組,發明專利,台灣,I363632,2012.5.11 ~ 2029.12.31
|
14﹒ |
BRAIN TISSUE DAMAGE THERAPIES,發明專利,美國,US 7,923,007 B2,2011.4.12 ~ 2028.7.31
|
15﹒ |
多能嗅覺幹細胞,發明專利,台灣,I313301,2009.8.11 ~ 2026.1.9
|
16﹒ |
分泌神經素於治療腦組織損害之醫療用途,發明專利,台灣,發明第I 305496,2009.1.21 ~ 2026.2.2
|
17﹒ |
分泌神經素於治療腦組織損傷之醫藥用途,發明專利,美國,US 7,427,597 B2,2009.1.21 ~ 2026.2.2
|
18﹒ |
Method of treating brain tissue damages,發明專利,美國,US7,427,597 B2,2008.9.23 ~ 2025.11.21
|
19﹒ |
使用人類臍帶血清的細胞培養基及方法,發明專利,台灣,第I300095號,2008.8.21 ~ 2025.7.19
|
20﹒ |
使用人類臍帶血清的細胞培養基及方法,發明專利,台灣,發明第I300095號,2008.8.21 ~ 2025.7.19
|
21﹒ |
治療腦血管疾病的組成物以及促進紅血球生成素表現的方法,發明專利,台灣,I327473,2007.8.14 ~ 2027.8.13
|
22﹒ |
Treating cerebrovascular diseases with erythropoietin and granulocyte-colony stimulating factor jointly,發明專利,美國,7,618,938 B2,2007.2.7 ~ 2027.2.6
|
23﹒ |
METHODS OF INCREASING NEUROTROPHIC FACTOR EXPRESSION,發明專利,美洲,US7,569,545 B2,2005.5.20 ~ 2025.5.20
|
|
獲獎/Award (獲獎名稱,給獎單位,獲獎日期)
|
1﹒ |
2023年度國家新創精進獎,社團法人國家生技醫療政策研究中心,2023.12.25
|
2﹒ |
第二十屆國家新創獎 學研新創獎,社團法人國家生技醫療科技政策研究中心,2023.12.27
|
3﹒ |
2023國家新創獎-學研新創獎 - 開發EphA10 三特異性抗體銜接免疫細胞藥物治療實體癌,,2023.10.27
|
4﹒ |
第二十屆國家新創獎 精準醫學-基因修飾之間質幹細胞的外泌體治療腦中風,財團法人生技醫療科技政策研究中心,2023.10.27
|
5﹒ |
第19屆國家新創獎,,2022.12.01
|
6﹒ |
第十九屆國家新創獎:學研新創獎,生策會,2022.12.03
|
7﹒ |
第17屆國家新創獎-學研新創獎,財團法人生技醫療科技政策研究中心,2020.09.25
|
8﹒ |
2020未來科技獎,國科會,2020.08.27
|
9﹒ |
第十二屆國家新創獎-學研新創獎,社團法人國家生技醫療產業策進會,2015.12.24
|
10﹒ |
趙百師老師論文獎,台灣腦中風學會,2014.11.01
|
11﹒ |
李悌愷教授優秀論文獎,台灣腦中風學會,2008.11.15
|
|
技術轉移/Technology Transfer (技術名稱,發明人,合約期間,專利名稱,授權單位,授權單位名稱)
|
1﹒ |
衍生自基因工程化之間質幹細胞的外泌體及其應用,鄭隆賓(Long-Bin Jeng)、徐偉成(Woei-Cheang Shyu)、洪明奇(Mien-Chie Hung)、林瑄翎(LIN SYUAN-LING)、陳建霖,2023.8 ~ 2043.8,,本校(含附醫),聖安生醫股份有限公司
|
2﹒ |
架接免疫調節抗體於奈米褐藻醣奈米藥物之組成及製程方法,徐偉成(Woei-Cheang Shyu)、謝佳宏(Chia-Hung Hsieh)、蔡長海(Chang-Hai Tsai)、林佑融、陳三元(San Yuan)、江智聖(Chih Sheng Chiang),2018.9 ~ 2038.9,架接免疫調節抗體於奈米褐藻醣奈米藥物之組成及製程方法,本校(含附醫),長新生醫國際股份有限公司
|
3﹒ |
間質幹細胞治療應用(多發性硬化症),徐偉成(Woei-Cheang Shyu)、謝佳宏(Chia-Hung Hsieh)、許重義(Chung Y. Hsu)、蔡長海(Chang-Hai Tsai)、林振寰(Chen-Huan Lin)、李瑋(Wei Lee),2018.6 ~ 2038.6,間質幹細胞於治療多發性硬化症之用途,本校(含附醫),長聖國際生技股份有限公司
|
4﹒ |
表現IGF1R之幹細胞治療心肌梗塞及幹細胞的應用,徐偉成(Shyu, Woei-Cherng),2017.3 ~ 2037.3,,本校(含附醫),長聖國際生技股份有限公司
|
5﹒ |
表現IGF1R之幹細胞治療腦損傷及幹細胞的應用(含Magnetic Nanoseaurchin應用技術),徐偉成(Shyu, Woei-Cherng),2017.1 ~ 2037.1,間質幹細胞、其純株化擴張之方法、其分離方法及其應用,本校(含附醫),長聖國際生技股份有限公司
|
6﹒ |
幹細胞應用技術,徐偉成(Woei-Cherng Shyu)、許重義(Chung Y. Hsu)、周德陽(Der-Yang Cho)、林振寰(Chen-Huan Lin)、李瑋(WEI LEE)、陳三元(San- Yuan Chen)、鄭隆賓(Long-Bin Jeng)、蔡長海(Chang-Hai Tsai),2016.7 ~ 2036.7,幹細胞應用技術,本校(含附醫),長新生醫國際股份有限公司
|
7﹒ |
表現IGF1R之幹細胞治療腦損傷及幹細胞的應用(含Magnetic Nanoseaurchin應用技術),徐偉成(Woei-Cherng Shyu),2015.12 ~ 2035.12,,本校(含附醫),長新生醫國際股份有限公司
|
|